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ABSTRACT
In Vitro Anafysis of Integrin Mediated Adhesion, 
Migration, and Signaling
by
William L. Rust
Dr. George Plopper, Examination Committee Chair 
Assistant Ârofessor of Biological Sciences 
University of Nevada, Las Vegas
Integrins are cellular adhesion receptors whose functions are critical to the 
progression of solid tissue cancers. The research described here involves four projects 
aimed at understanding how integrins modulate key elements of carcinogenesis,
(adhesion and migration), on laminin basal lamina proteins.
In order to carry out these studies, a novel fluorescence based protocol for quantifying 
cell migration towards a bound substrate was developed (Chapter 2). This method is more 
reliable, efficient, and informative than currently available protocols. 1 demonstrate its 
use as a screen for migration-blocking chemotherapeutic drugs.
The small heat shock protein 27 (HSP27) is found to be over-expressed in many 
mammary carcinomas and can be an effective prognosticator of disease recurrence
111
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following treatment. The mechanisms for this action of HSP27 are not folly understood. 
In chapter 3,1 demonstrate that over-expressed and activated HSP27 enhances migration 
towards laminin-5 in breast carcinoma cells through an intracellular signaling pathway 
involving mitogen activated protein kinase (MAPK/ERK 1/2). In addition, non-activated 
HSP27 in the same cells confers resistance to a subset of drugs that would halt migration.
In a screen of drugs that block the fonction of specific intracellular signaling 
molecules, it was found that an inhibitor of G-protein mediated signaling blocked the 
integrin induced migration of breast epithelial cells on laminin-5.1 demonstrated in 
chapter 4 that pro-migratory signaling cascades stimulated by the P1 class of integrins are 
inhibited specifically by interruption of Ga, and not Gets heterotrimeric G-protein 
isoforms. Furthermore, p i stimulation caused an increase of an intracellular G-protein 
effector (cAMP). Artificial manipulation of cAMP mimicked the effects of p i 
stimulation on migration of these cells. These data suggested for the first time that G- 
proteins function in integrin stimulated signal cascades.
Because most cells express several types of integrins simultaneously, in chapter 5 1 
constructed a model whereby the contribution of individual integrin types to the net effect 
of integrin engagement could be analyzed. For this 1 demonstrated that intracellular 
calcium flux can be used as a reliable downstream marker of integrin stimulated signaling 
cascades, and that laminin-1 is a good model substrate for stimulating a variety of 
integrin subtypes. Next I describe the production and testing of six recombinant 
fi-agments of laminin-1 for the purpose of producing activating ligands of specific 
laminin-1 binding integrins.
IV
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CHAPTER 1
GENERAL INTRODUCTION 
The behavior of ail living cells is controlled by three extrinsic factors. These are the 
conditions of the immediate environment (pH, temperature, salinity, osmolality, 
irradiation), the static environment (molecules of connective tissue and neighboring 
cells), and the soluble environment (mitogens, endocrine and paracrine signals, 
hormones). This also holds true for tumorigenic cells of the human body. Regardless of 
gene expression patterns or mutations, the progression of human cancers is dependent 
upon cellular interactions with the microenvironment. Although much research into 
cancer progression has been accomplished, it remains largely unknown how a 
tumorigenic cell’s microenvironment enhances or blocks cancer growth. In order to 
understand the cumulative effect of these extrinsic factors in controlling the progression 
of human cancers, the impact of each must first be fully understood.
The research described here focuses on understanding the cellular interaction of 
normal and tumorigenic epithelial cells with a component of the static environment, the 
basal lamina, in exclusion of all other influences. Specifically, the interaction between the 
integrin class of adhesion receptors and laminins, the most abundant members of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2basal lamina [1]. Each chapter describes a project aimed at understanding the specific 
intracellular signaling stimulated by integrin engagement to lam inins, or quantifying 
integrin-mediated adhesion and migration on laminins.
Integrins are not the only receptors by which cells interact with the static 
environment, but are the major receptors by which the cells of solid tissues interact with 
the basal lamina [2]. Four other families of adhesion molecules have been identified. 
These are the cadherins, the immunoglobulin (Ig) superfamily, selectins, and CD44 [3]. 
Cadherins are a family of transmembrane glycoproteins that mediate cell-cell adhesion 
via homotypic (cadherin to cadherin) interactions and are fundamental determinants of 
tissue organization in developing and adult organisms [3-5]. Ig superfamily adhesion 
molecules are characterized by the presence of immunoglobulin-like domains. This 
family mediates endothelial cell interactions with lymphocytes, monocytes, neutrophils, 
and tumor cells that result in adhesion and trans-endothelial migration. Selectins are 
transmembrane glycoproteins that mediate heterotypic interactions between blood and 
endothelial cells during lymphocyte homing and leukocyte adhesion. CD44 is a widely 
distributed integral membrane glycoprotein shown to facilitate lymphocyte homing and 
T-cell activation, and is the primary cell surface receptor for hyaluronan [3]. Finally, 
integrins are transmembrane heterodimers that are obligatory on the plasma membrane of 
every mammalian cell type, and the focus of the majority of cell adhesion research [6].
The importance of integrin function in mammals is evidenced by gene knock-out 
studies in mice. Deletion of individual integrin subtypes leads to unique phenotypes with 
little overlap, and most deletions are perinatal lethal. In fact, deletion of a class of 
integrins (Pl) results in embryonic lethality by day five. [7,8].
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As our understanding o f cancer development grows, it has become clear that the 
integrin family of cell adhesion receptors play an important role in virtually every stage 
of cancer progression. Although integrins are not oncoproteins, they help modulate the 
processes of cell growth, death, migration, and invasion, which all impinge on the 
severity of clinical disease [9]. It is common to find that oncogenic transformation 
accompanies changes in integrin expression and substrate preference. Several drugs in 
clinical trials fimction as integrin antagonists, all having shown promise as anti- 
angiogenic, anti metastatic, and anti-proliferative compounds in mice models [10-12]. It 
is from studies of tumorigenic tissues and cells that much of our understanding o f integrin 
fimction has emerged.
Basal Lamina
The basal lamina are sheets of extracellular matrix (ECM) that line all the cavities and 
free surfaces of the body, forming barriers from one body compartment to another. Made 
and organized by epithelial cells, the ECM provides an adhesive substrate, transmits 
signals through adhesion receptors, and binds, stores, and presents growth factors. During 
embryogenesis, the basal lamina fimctions to promote proliferation, differentiation, and 
migration of embryonic cells. In adults, the basal lamina fimctions as a molecular filter, 
polarizing epithelial cells, shaping the tissue structures, supporting infiltration of 
immunocytes, and guiding the migration of regenerating cells following injury [8, 10]. 
The components of the extracellular matrix are polysaccharide chains of the class called 
glycosaminoglycans, structural fibrous proteins (collagen and elastin), and adhesive
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
proteins, (fibronectin and laminin). The polysaccharide chains are usually found 
covalently linked to protein in the form of proteoglycans.
Laminins are the first ECM proteins expressed in the developing embryo (2-4 cell 
stage), they are the most abundant basal lamina protein, and they are found in every adult 
basal lamina [1,13]. These are a family of heterotrimeric glycoproteins composed of a 
single a  (~400kDa), P (-200 kDa), and y (~200kDa) chain (figure 1). Diversity within 
the laminin family is achieved by forming different combinations of aPy trimers [13]. 
Currently, twelve lam inin isoforms are known. Each chain is composed of 2-4 N-terminal 
globular domains cormected to a large coiled-coil region. The a  chains have an additional 
C-terminal domain composed of five repeating globular subdomains. The three chains 
interact solely at the coiled-coil region, and are stabilized by disulfide bonds, forming an 
overall cross-shaped structure [13].
The laminins of interest for this study are laminin-5 and laminin-1. Laminin-5 is 
abundantly expressed in the basal lamina of breast tissue, and is the preferred adhesive 
substrate of many breast carcinoma cells. In addition to being expressed as several splice 
variants, laminin-5 is modified in vivo by proteases which recognize cleavage sites on the 
a  and y short arms [14]. Modification of this isoform is shown to alter the migratory and 
invasive properties of tumorigenic epithelial cells and is found at the leading edge of 
metastatic invasion [13]. Laminin-1 is the first discovered and best studied of all the 
laminin isoforms. It is isolated from murine Engelbreth-Holm-Swarm (EHS) cells and is 
commercially available. This isoform is used in our studies as a model substrate for that 
research advantage.
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Figure 1. Structure of laminin-1.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6Integrins
Integrins are the Major Class o f ECM receptors
Integrins mediate adhesion to extracellular matrix proteins and, in a few cases, cell­
cell adhesion. There are currently 18 a  and 8 p subunits known which interact to form at 
least 24 ap heterodimers. Most cells express more than one integrin isomer, which are 
loosely distributed over the cell’s surface. Integrin expression is different between cell 
type, and changes with developmental stage and physiological conditions within a cell 
type [15,16]. This family of receptors can be classified into three subfamilies. The pl 
integrins generally mediate interactions between cells and ECM. The P2 integrins are 
restricted to leukocytes and are typified by having other cell surface proteins as their 
ligands. The P3 integrins are almost exclusively expressed on platelets and 
megakaryocytes and act as important mediators of platelet adhesion [6].
Excepting the fibronectin receptor a5p i, all integrins recognize and bind to more 
than one ECM molecule. Each ECM molecule is also known to be bound by more than 
one integrin. Although it is impossible to predict an integrin binding site based on 
sequence, an acidic residue is common to all known binding sites, and many contain the 
sequence RGD [12].
Integrins on resting cells do not adhere strongly to their ligands, but are rapidly and 
reversibly activated by cellular agonists. The affinity of integrins for their ligand is 
enhanced by conformational changes to their dimeric structure. Adhesive strength is 
increased through lateral clustering of integrins at points of cellular contact, a process 
termed avidity [6,17].
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Integrins are heterodimeric glycoproteins
Both a  and P subunits are composed of a large, stalk like C-terminal extracellular 
domain, a single transmembrane segment (-20 aa), and with the exception of P4, a small 
(-250aa) globular cytoplasmic domain stabilized by intrapeptide disulfide bonds. The a  
chain globular head is composed of a sub-domain of seven homologous 60aa repeats that 
are predicted to form a P propeller structure containing three or four EF hand type 
divalent cation binding motifs. Nine a  subunits have an additional domain termed the 1 
domain which is the site o f a Mg/Mn metal ion-dependent adhesion site (MIDAS) [12,
17,18]. In addition, all integrin a  subunits contain a highly conserved KXGFFKR motif 
adjacent to the transmembrane domain that is the proposed binding site for several 
integrin binding proteins [19,20]. All p chains have a conserved N-terminal globular 
domain of -240aa which is similar to the a  1 subdomain. The p 1-like domain contacts 
the p-propeller domain of the a  chain and is responsible for the association between the a  
and p chains through stabilizing salt bridges involving the cation binding motifs [12,17].
Although exceptions are easily found, the extracellular domain of the a  chain is 
thought to confer ligand specificity, while the cytoplasmic domain of the p chain is 
implicated as the major binding site for interacting cytosolic proteins [12,19]. Two of the 
cytosolic proteins that are thought to regulate the activation state of the extracellular 
domains are the Ras family of GTPases and protein kinase C (PKC) [6,21]
A common, although unproven, model for integrin activation presumes that ligand 
recognition involves the close association of the C-termini of the a  and P subunits. Like 
the action of opening scissors, this forces a break in the salt bridges holding the
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gcytoplasmic domains in contact, opening up binding sites for integrin associated 
cytoplasmic proteins [IS].
At sites of integrin activation and clustering, protein aggregates termed focal 
complexes and focal adhesions assemble on the intracellular surface. The types of 
proteins that form these complexes can be grouped as either structural, which form links 
to the actin cytoskeleton, or signaling, which include a variety of kinases and adapter 
molecules linking integrins to still more kinases, members of the GTPase families, 
phosphoinositide signaling, and ion release (Fig. 2) [20,22,23]. The structural 
components are talin, a-actinin, vinculin, and filamin. Talin, a-actinin, and vinculin are 
capable of binding F-actin, while filamin is an actin filament cross linking protein. O f 
these, only a-actinin is shown to bind directly to integrins, while the others are capable of 
binding each other and members of the signaling component [18,24,25]. These 
complexes are sites where the cell can generate tension with respect to its surroundings, 
allowing the cell to alter its shape and carry out complex processes such as migration and 
cell division [12,26].
The signaling proteins found at focal complexes and focal adhesions associate with 
integrin cytoplasmic domains to form a nexus for stimulating intracellular signaling 
cascades. At these sites, signaling fi’om outside to inside the cell occurs which contributes 
to the regulation of diverse cellular processes including entry into the cell cycle and 
programmed cell death (apoptosis), gene transcription, regulation of intracellular pH, 
differentiation, and migration. Signaling through integrins from the inside to the outside 
of the cell regulates adhesive strength through affinity and avidity modulation, and helps
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 2. Model of signaling complex (A), and structural complex (B) 
formed at focal adhesions.
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10
in remodeling of the extracellular matrix in the processes of tissue development and 
tissue invasion.
Integrins are signaling receptors 
Outside-in
Except that integrins have no intrinsic enzymatic activity, there is little justification 
for drawing a distinction between integrin and soluble factor receptor signaling [6,15]. 
Nearly all intracellular signaling events stimulated by growth factors can be at least 
transiently stimulated by integrins. In fact, many mitogenic responses, including 
activation of the mitogen activated protein kinases (MAPKs) require integrin activation 
for a strong or sustained response [27].
Most attention placed on integrin linked signaling focuses on the 125kDa kinase 
termed focal adhesion kinase (FAK). Although FAK lacks Src homology (SH2 and SH3) 
binding domains and the ability to anchor to the membrane, it has numerous tyrosine and 
serine/threonine phosphorylation sites that act as docking sites for the recruitment and 
activation of several SH2- and SH3-containing classes of signaling molecules. The FAK 
regulated signaling complexes form a complicated, and seemingly redundant association 
of adapter molecules that stimulate overlapping signal cascades (Fig. 2) [20,28]. Talin 
and paxillin are implicated in the activation of FAK by stimulating its 
autophosphorylation on Y397. This opens a binding site for the oncoprotein Src. All three 
of these molecules are implicated in targeting FAK to the focal adhesion. Src also 
phosphorylates FAK on a number of residues, including Y925. Grb2 binds this motif, and 
through the action of the guanine nucleotide exchange factor SOS, connects activated 
receptor tyrosine kinases to Ras/ERK/MAP kinase cascades, [12,23,28,29].
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Phosphatidyl Inositol 3-Kinase (PI-3K) also binds to Y397, and mediates cell 
proliferation, cell migration, and apoptosis through its downstream effector PKB/Akt [16, 
21]. P130CAS is an adapter molecule containing SH2 and SH3 binding motifs that also 
binds to FAK and is phosphorylated by FAK/Src. P130cas is implicated in activating the 
ERK cascade as well as Jun N-terminal kinase (JNK). Both pl30Cas and FAK, through 
the ERK pathway, are implicated in the activation of several transcription factors [29].
FAK is also implicated in preventing apoptosis through a pathway involving PKC, 
phospholipase A2 (PLA2), and p53, and in controlling cell cycle progression [27,29].
Integrin regulated signaling proteins that can be activated independent of FAK 
include protein kinase C (PKC), integrin linked kinase (ILK), integrin associated protein 
(lAP) and the tetraspan (TMS4F) adapter proteins [12,28]. ILK’s only known substrate 
is integrins, and may function as a bridge to FAK [12]. Although tetraspans can regulate 
cell motility, their mechanism of action is not understood [30].
Inside-out
The main consequence of inside out signaling is changes in integrin adhesive strength 
through affinity and avidity modulation. Exactly how this occurs is unknown, but 
phosphorylation of integrin subunits may be important in both processes [6]. Intracellular 
calcium is shown to decrease integrin affinity while Ras family GTPases can convert 
integrins to a high or low affinity state, depending on the cell type [21]. PKC is thought 
to cause the increase of both integrin affinity and integrin avidity [6].
Integrins Contribute to Cancer Progression
Solid tissue cancers begin as benign aggregates of poorly differentiated cells which 
have, through a range of possible mutations, lost the normal mechanisms regulating cell
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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growth and/or cell death. Although not well studied, integrins are shown to influence 
proliferation through cooperation with growth factor receptors, by specifically causing 
the transcription of the cyclins and cyclin dependent kinases (Cdks) required for 
transition past the G1 checkpoint, and by down-regulation of Cdk inhibitors [6,12,27].
Progranuned cell death, or apoptosis, is regulated by the action of death effector 
molecules and resistance mechanisms that counteract the pro-apoptotic signals. The 
ultimate apoptosis effectors are the caspase family of proteases [12]. The fact that most 
cells deprived of ECM interactions undergo apoptosis, and that integrin ligation can 
rescue those cells demonstrates that integrins are involved in stimulating the apoptosis 
resistance mechanisms [12]. Proteins known to be part of those resistance mechanisms 
include MAPK, NFkB, Bcl-2, Pl-3 kinase, INK and PKB/Akt. In some cell lines, 
integrins are shown to activate the Bcl-2 gene, while others report that integrins increase 
the activity of MAPK, JNK, PI-3 kinase, and PKB/Akt [6,12,16,21]. In addition, 
integrin dependent interaction with the ECM can suppress the activity of caspase-1 [6]. 
Lastly, cell death by deprivation of engagement of ECM (anoikis) may be an important 
control mechanism in cancer since carcinoma cells that lose contact with the matrix 
would die rather than circulate and colonize distant sites [16,21].
Benign tumors are encapsulated by an organized lattice o f basement membrane 
components. The progression to malignancy, and the clinical diagnosis of malignant 
disease, is essentially determined by the capability of tumor cells to dissociate, degrade 
the lattice, and metastasize to other locations within the body. This process, termed the 
metastatic cascade, begins with the detachment of single tumor cells and active 
infiltration by those cells to the surrounding stroma where entry into the vasculature and
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lymphatic system is possible. Dissociation of individual cells from a tumor mass is 
regulated by the E-cadherin family of receptors. These are shown to be suppressors of 
epithelial tumor metastasis. Recently, activation of integrin o3p 1 was shown to down- 
regulate E-cadherin mediated adhesion, causing loss of cell-cell adhesion, junctional 
communication, and enhancing invasiveness of malignant tumor cells [4].
For invasion by dissociated cells to occur, the ECM that surrounds the neoplastic 
tissue must be degraded to allow the escape of invasive cells. Integrins participate in the 
ECM degradation by stimulating the secretion of ECM-degrading proteases. Integrin 
expression is shown to cause the secretion of the matrix metalloprotease (MMP) family 
of proteases in vitro, and enhance invasion in vivo, through a signaling cascade involving 
Ras[12,21].
Integrins effect the active migration of cells in the following manner: Membrane 
protrusions (lammelipodia and filopodia) are formed at the leading edge of migrating 
cells which attach to the substrate by forming focal complexes. The integrin-stimulated 
signaling molecules conclusively shown to regulate the formation of lammelipodia and 
filopodia are Rac and Cdc42, while Rho is shown to inhibit the formation of these 
structures by forming and maintaining stable actin stress fibers. At the trailing end, focal 
adhesions are disassembled with the help of calpain and gelsolin, and the integrins are 
recycled to the leading edge. Movement of the cell body is accomplished by contraction 
of the actin-myosin cytoskeleton which is also triggered by integrin stimulated signal 
cascades [5,21,26,31,32]. The rate of cell migration can be plotted as an approximate 
bell curve versus the extent of cell adhesion. With low-strength integrin binding, 
migration is relatively slow because weakly attached cells do not generate enough
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
14
traction to move significantly. An optimal rate of migration is achieved with increasing 
adhesion, and further cell attachment impairs motility by binding the substrate too 
strongly to allow efficient movement [33].
Once in the vasculature, cells are trapped in the microvessels o f target organs. For this 
reason, the lung, liver, kidney, and lymph nodes are common sites o f metastasis for most 
tumors. Once trapped, a percentage of these cells will cross the endothelial cell barrier 
and, through an act of ECM remodeling and migration as discussed above, invade the 
host tissue. These cells can be killed by the immune system or remain donnant for many 
years. Following stimulation by unknown factors, these cells may exit dormancy, begin 
to divide, recruit blood vessels, and form a secondary tumor.
Mechanisms o f integrin function are not fully understood
Although much investigation into the mechanisms of integrin function has been 
accomplished, it remains unknown how signaling specificity by members of this receptor 
family is achieved. In other words, it is unknown how a few engaged integrin subtypes 
can regulate the complex behaviors described. It is my hypothesis that, with some 
overlap, engagement to ECM can stimulate signaling cascades specific to each integrin. 
This can cause a dynamic intracellular signaling response through mechanisms of 
integrin crosstalk. Specifically, I hvix)thesize that laroinin binding integrins are capable 
of independently and simultaneously stimulating several intracellular signal cascades that 
cooperate with one another to regulate the strength of adhesion and rate of mieration. The 
research described in each of the following four chapters either supports this hypothesis, 
or provides a method for studying these phenomena.
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The following chapter describes a novel protocol for quantifying integrin mediated 
cell migration. This protocol provides a simpler, more efficient, and more reliable method 
than previously available. The protocol is presented as a means for measuring the anti- 
migratory effect of current and experimental anti-cancer chemotherapies. Because most 
chemotherapies are cytotoxic, and general cellular cytotoxicity is likely to influence cell 
migration, the protocol includes a simultaneous quantification of cell death amongst the 
population of cells that have failed to migrate.
Chapter three investigates the influence of heat shock protein 27 (HSP27) on integrin 
mediated cell migration. HSP27 is a small chaperonin protein implicated in resistance to 
apoptosis and disease recurrence following chemotherapy. I show that activation of 
constitutively over-expressed HSP27 enhances migration of a malignant breast cell line 
in vitro and induces resistance to a subset of drugs that inhibit integrin-stimulated 
migration on the ECM protein laminin-5.
Chapter four provides evidence of a link between pi-containing integrins and 
heterotrimeric G-proteins in the stimulation of breast cell migration on the ECM protein 
lam inin-5- Previous to this study, heterotrimeric G-proteins had not been implicated in  
pro-migratory integrin-stimulated signaling cascades. The involvement of this class o f 
signaling molecules is demonstrated through the use of specific inhibitors of 
heterotrimeric G-proteins, artificial modulation of the G-protein effector molecule cAMP, 
and integrin stimulating antibodies.
In chapter five I build a model to identify mechanisms of integrin cooperation that 
have the potential of instilling this class of signaling molecules with the specificity 
required for modulating the variety of effects attributed to them. I describe the production
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of recombinant fragments of laminin-1 for the purpose of creating proteins that 
specifically stimulate individual laminin-1 binding integrin subtypes. In addition, the 
usefulness of intracellular calcium flux as an indicator of integrin cooperation is 
demonstrated.
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CHAPTER 2
SCREENING ASSAY FOR PROMIGRATORY/ 
ANTIMIGRATORY COMPOUNDS
This chapter has been published in Analytical Biochemistry and is presented in the style 
of that journal. The complete citation is:
Rust, W.L., Huff, J.L., Plopper, G.E. 2000. Screening Assay for 
Promigratory/Antimigratory compounds. Analytical Biochemistry 280, ppl 1-19.
Abstract
Large scale screening strategies aimed at finding anti-cancer drugs traditionally focus 
on identifying cytotoxic compounds that attack actively dividing cells. Because 
progression to malignancy involves acquisition of an aggressively invasive phenotype in 
addition to hyperproliferation, simple and effective screening strategies for finding 
compounds that target the invasive aspects of cancer progression may prove valuable for 
identifying alternative and preventative cancer therapies. Here, we describe a 
fluorescence based automated assay for identifying anti-migratory compounds, with the 
ability to discern cytotoxic from non-cytotoxic modes of action. With this assay, we 
analyzed the effects of two drugs on tumorigenic (MDA-MB-435 ) and non-tumorigenic
22
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(MCF-IOA) human breast cell lines. We chose to compare carboxyamido-triazole (CAI), 
an experimental compound shown to inhibit migration of various cell types, with 
tamoxifen, a common preventative and therapeutic anti-cancer compound. Our assay 
demonstrated that both these compounds inhibit migration at sub-lethal concentrations. 
Furthermore, CAI was more effective than tamoxifen at inhibiting chemotactic and 
h^totactic migration of both cell lines at all concentrations tested.
Introduction
Cancer progresses in two general stages. It begins as a carcinoma of clonal, 
hyperproliferating cells confined to the tissue of origin, which may exist for years as a 
benign, primary tumor. The conversion of a benign tumor to malignancy involves the 
acquisition of an aggressively invasive phenotype, wherein the cancer cells leave the 
tissue of origin and establish new tumor métastasés at distant sites. Métastasés are first 
evident at local lymph nodes, with the severest patient prognosis associated with 
métastasés located at distant sites (1).
There are limitations to common chemotherapy regimens. The most conunon drugs 
for treating solid tissue cancers are cytotoxic compounds that interfere with the synthesis 
or function of nucleic acids. These drugs target actively dividing cells of established 
tumorigenic colonies (2). While many are effective at treating earlier stage cancers, none 
are curative for later stage disease, when overt métastasés are already evident. Because 
many tumors are not diagnosed until advanced stages, the effectiveness of these drugs is 
limited (3). In addition, these anti-proliferative agents produce damage to normal tissues, 
such as immune suppression, mucositis, and hair loss, as well as side effects such as
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nausea and vomiting (2,4). It is important, therefore, to identify alternative, and 
potentially less toxic treatments for halting the spread of cancer. These strategies focus on 
preventing the conversion of tumorigenic cells to the m alignant phenotype, as opposed to 
arresting cell growth. For example, recent chemotherapeutic advancements include the 
introduction of compounds with non-cytotoxic mechanisms of action, such as anti- 
angiogenic factors, growth factor antagonists, interferons, and agents that induce cellular 
differentiation (5-8). These non-cytotoxic compounds will potentially be used to prevent 
the spread of cancer, as well as to increase the effectiveness of cytotoxic drugs. Since the 
conversion from hyperproliferative to invasive disease typically takes many years, a large 
window exists for the use of preventative therapies (1,3).
The cellular changes required for malignant conversion are complex, offering a large 
and diverse array of potential targets for the development of anti-metastatic drugs. A 
common theme among these cellular changes is aberrant regulation of cell migration. 
Examples of these changes include secretion of proteases, decreased synthesis of protease 
inhibitors; loss of cell-cell contacts; modifications of cell-substrate interactions; and 
alteration in the response to and production of chemotactic and haptotactic stimuli during 
tumor induced angiogenesis and/or metastasis (reviewed in 9, 10, 11). The identification 
of compounds that halt cell migration without inducing cell death may lead to creation of 
novel compounds that are less toxic than common anti-proliferative agents (3).
Carboxyamido-triazole (CAI) is an example of such an anti-migratory compound, 
which is currently in stage 2 clinical trials of androgen-independent prostate cancer (12). 
CAI is an inhibitor of non-voltage gated calcium chaimels and blocks cell migration or 
invasion in breast cancer cell lines (13), prostate cancer cell lines (14), ovarian cancer cell
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lines (3), and head and neck squamous cell carcinomas (15). The anti-proliferative effect 
of CAI is cytostatic, not cytotoxic, as cells will recover after the removal of CAI (14,16). 
This indicates that CAI inhibits signal cascades specific to migration and proliferation. 
Established modes of action for CAI include inhibition of nucleotide metabolism by 
depleting phosphoribosyl pyrophosphate (16), inhibition of arachidonic acid and 
phophoinositide generation (17), and reduction of matrix metalloproteinase activity (13, 
18).
While compounds such as CAI hold promise for effective cancer therapy, there is a 
lack of screening strategies aimed at identifying these non-cytotoxic, anti migratory 
compounds. Here we present a fluorescence based, high-throughput method for screening 
potential anti-migratory compounds that is designed to discern cytotoxic fi’om non- 
cytotoxic mechanisms of action. Using 96 and 24 well migration filter plates with 
fluorescence-opaque filters, we show that cell migration can be quantitated easily and 
reliably with the use of the fluorescent dye calcein-AM. Cytotoxicity of compounds 
tested is determined by labeling non-migrated cells with the fluorescent DNA intercalator 
propidium iodide. The experimental cells are doubly labeled so that migration and 
cytotoxicity are measured in the same assay. The use of a high throughput format, and the 
novel incorporation of screens for both anti-migration and cytotoxicity on the same test 
cells, represents major improvements in efficiency and cost over traditional trans-filter 
migration assays.
With this method, we analyzed the effects of CAI and the well-established anti-breast 
cancer compound tamoxifen on migration and viability of two human breast cell lines.
Both compounds inhibited migration of the breast cancer cell line MDA-MB-435 and the
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non-tumorigenic breast ceil line MCF-lOA at sub-cytotoxic concentrations. Our assay 
demonstrated that, while MDA-MB-435 cells showed resistance to CAI induced cell 
death, CAI inhibited h^totactic and chemotactic migration of both cell lines more 
effectively than tamoxifen.
Material and Methods
Materials
MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Thiazolyl blue) 
was purchased from Sigma-Aldrich Chemicals (St. Louis, MO). Calcein-AM was 
purchased from Molecular Probes (Eugene, OR). Tamoxifen citrate was purchased from 
Calbiochem-Novabiochem (La Jolla, CA). Carboxyamido-triazole (CAI) was a generous 
gift of Dr. Elise C. Kohn (Laboratory of Pathology, National Cancer Institute, National 
Institutes of Health, Bethesda, MD). 96 well fluorescence blocking migration plates were 
provided by Polyfiltronics (Rockland, MA). 24 well fluorescence blocking migration 
plates were a generous gift of Dr. Nancy Chung-Welch, Becton Dickinson (Bedford, 
MA). Information regarding the commercial availability of the 24 and 96 well 
fluorescence blocking migration plates can be found at the Becton Dickinson website 
(www.bd.com/labware/newprod/fluoroblok.html). Transwell migration plates were 
purchased from Costar (Cambridge MA).
Tissue Culture
MCF-lOA and MDA-MB-435 cells were maintained as previously described (19). 
Cells were routinely passaged using trypsin/EDTA (Irvine Scientific).
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Transwell Migration Assay
Migration assays were conducted as previously described (20), with the following 
modifications. Transwell filters (8.0 pm pore size. Costar, Cambridge MA) were coated 
with purified bovine fibronectin, mouse laminin-1 and collagen IV at 20pg/ml in 
carbonate buffer (pH 9.3), for one hour at room temperature. 120,000 cells were 
suspended in DME with 292pg/ml L-Glutamine, 100 units/ml penicillin g, 100 mg/ml 
streptomycin sulfate (GPS, Irvine Scientific, Santa Ana, CA) and 1 mM sodium pyruvate 
(Gibco BRL, Grand Island, NY), plated on the uncoated side of the filter and incubated in 
a humidified incubator containing 5% CO2 Filters were washed twice in phosphate 
buffered saline (PBS) and the uncoated side of each filter was wiped with a cotton tipped 
applicator to remove cells that had not migrated. Cells were then fixed in 3.7% 
formaldehyde for 15 minutes, and stained with crystal violet as in the adhesion assay. 
Stained cells of four representative fields of each filter were counted at 400X 
magnification.
96 and 24 Well Fluorescence Migration Assay
An individual filter insert and well of a 24 or 96 well migration plate is indicated in 
Fig. 1. Both 24 well and 96 well migration plates are designed as a single insert 
containing all filter wells in one piece. Each filter insert (A) has a UV opaque membrane 
(B) with 8.0 pm pores. Inserts fit into a well (C) of a 24 or 96 well reservoir plate. The 
underside of the filters were left uncoated, or coated with 20 pg/ml bovine plasma 
fibronectin, type IV collagen, or laminin-1 (Gibco BRL, Grand Island, NY) in 0.1 M 
acetic acid, and allowed to evaporate. The filter insert was submersed in wells of feeder 
plate containing DME with IX GPS and 1 mM sodium pyruvate or DME supplemented
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FIG. 1. Individual filter insert and feeder well of a 24 or 96 well migration plate. Test 
cells are loaded into filter insert (A), and allowed to migrate across a fluorescence opaque 
filter (B) towards media in feeder well (C). Cells are subsequent^ labeled with 
fluorescent indicators of cell migration and cell death. Emitted fluorescence of m^rated 
cells is measured fiom underneath the filter (D). Emitted fluorescence o f non-viable cells 
is measured from above the filter (£).
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with IX GPS and 10%FCS. 100,000 cells suspended in DME with IX GPS and 1 mM 
sodium pyruvate were added to the inside of each filter well (80pl and lOOpl for the 96 
and 24 well plates, respectively). For drug studies, drugs were added to cell suspension 
immediately before loading cells into migration plate. 30 minutes before the end of the 
migration assay, calcein-AM was added to the feeder wells at a final concentration of 
5pM. Filters and wells were washed twice in PBS to remove excess dye. Fluorescence of 
calcein-AM labeled cells was measured firom the bottom of the plate (D) in a Tecan 
SpectraFluor plate reader (Research Triangle Park, NC) with 485 nm excitation and 530 
run emission filters. As an indicator of cell death, propidium iodide fluorescence was 
measured fix)m the top of the filter insert (E).
Quantification o f Cell Death
Cells grown in 96 well plates were incubated for four hours in 200 pi per well of the 
appropriate media supplemented with 1.25mg/ml MTT (3-[4,5-Dimethylthiazol-2-yl]- 
2,5-diphenyltetrazolium bromide; Thiazolyl blue). To release reduced MTT from viable 
cells, 150 pi o f media was replaced with acidic isopropanol (99.7% isopropanol, 0.3%
12. IN HCl) and wells were incubated overnight at room temperature. Absorbance was 
measured at 570nm vs. 630nm reference using a Tecan SpectraFluor. Quantification of 
cell death by fluorescence was performed as previously described (21). Briefly, 1.2 mM 
propidium iodide was added to media of test wells or filters to reach a final concentration 
of 30pM and incubated for 30 minutes at 37®C. As a positive control, cells were lysed in 
1% Triton X-100 (Sigma, St. Louis, MO) detergent during incubation with propidium 
iodide. Fluorescence of incorporated dye was measured at 560nm excitation, and 645nm 
emission wavelengths using a Tecan SpectraFluor.
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Statistical Analysis
Anova/T-test was perfonned on data from indicated figures using a 95% confidence 
interval. All experiments were conducted at least three times with four to sixteen 
replicates per condition.
Results
Fluorescence o f Labeled Cells Correlates Linearly with Cell Number
In order to quantify migrated cells automatically, cells were labeled with the live cell 
fluorescent indicator calcein-AM, and a standard curve comparing relative fluorescence 
units (RFU) vs. cell number was obtained (Fig. 2). Specific numbers of pre-labeled MCF- 
lOA cells were plated in a 96 well tissue culture plate and RFU measurements of these 
cells correlated linearly with cell number (Fig. 2A). Because the plate reader parameters 
and dimensions of the plates are slightly different in a  migration assay, we confirmed this 
correlation of cell number with RFU on migratory cells on the bottom of the migration 
filter. MCF-lOA cells were allowed to migrate towards serum through transparent 
transwell filters. Non-migratory cells were removed from the upper wells, and migratory 
cells measured by both calcein-AM labeling and visual counting of cells in five 
representative fields o f each filter (Fig. 2B). Similar results were observed with MDA- 
MB-435 cells (data not shown).
A UV Opaque Membrane Allows for Detection o f Migratory vs. Non-Migratory Cells 
The use of a fluorescence opaque membrane simplifies migration assays and allows 
separate detection of fluorescently labeled cells on either side of the membrane. The 
absorption spectrum o f the membrane used in our assay is effective at blocking a UV
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FIG. 2. Calcein-AM fluorescence correlates linearly with cell number. (A) The indicated 
number of prelabeled MCF-lOA cells was plated in a 96-well plate and fluorescence 
intensity was measured. (B) Chemotactic migration o f30,000-120,000 MCF-lOA cells 
was measured in a transwell migration fiher by calcein-AM fluorescence (y axis) and 
subsequently the cells were fixed and stained, and representative fields counted (x axis). 
Error is represented as the standard deviation of 8 wells.
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signal through the membrane if  either the emission or excitation wavelength of the 
fluorescent indicator used falls within the absorption band (data not shown and ref. 22). 
These filters effectively block the fluorescence (>95%) firom the opposite side of the 
membrane of either of the dyes used in our assays (data not shown and ref. 22). This 
membrane simplifies endpoint analysis by eliminating the need to remove non-migratory 
cells before quantifying migratory cells. MCF-lOA and MDA-MB-435 cells were 
allowed to migrate through fluorescence opaque filters of 96 or 24 well filter plates 
towards serum (chemotaxis) or the indicated matrices (haptotaxis), and migration was 
quantified by calcein-AM labeling (Fig. 3). The data in figure 3 demonstrate that both 
cell lines migrated more towards fibronectin than other matrices. For this reason, 
fibronectin was chosen as the haptotactic stimulus for all drug studies. Note that 
fluorescence values for each cell line cannot be directly compared to each other as 
different cell lines exhibit different labeling efficiencies. For example, MCF-lOA cells 
emit a fluorescence that can be as much as 40% brighter than that emitted by similarly 
labeled MDA-MB-435 cells (data not shown).
Cytotoxic Properties o f Drugs can be discernedfrom Anti-Migratory properties with the 
Fluorescent Indicator Propidium Iodide
Because a cytotoxic compound will halt migration by killing cells, the cytotoxic 
effects of tested compounds must be evaluated in screens for anti-migratory drugs. To 
this end, we incorporated a fluorescence based cytotoxicity assay that was performed in 
the upper well of the migration plate immediately following the migration assay. This 
protocol was adapted firom Nieminen et al. (21). The DNA intercalator propidium iodide 
is a cell impermeant dye whose fluorescence is increased 10 fold upon binding DNA
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FIG 3. MCF- lOA and MDA-MB-435 cells each migrate with different strength towards 
serum and bound matrices. 120,000 cells were allowed to migrate towards the indicated 
stimulus in 24 and 96 well filter plates with fluorescence opaque filters. Migrated cells 
were quantified ly  calcein-AM fluorescence. Error is represented as standard deviation of 
16 wells.
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(23). The dye is incorporated into membrane compromised, non-viable ceils, and is 
excluded from viable cells. Propidium iodide was added to the upper well o f the 
migration plate thirty minutes before the end of the migration assay. Propidium iodide 
fluorescence measurements inversely correlated with results obtained with the 3-[4,5- 
Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Thiazolyl blue (MTT) cell 
viability assay in experiments where cells were exposed to increasing concentrations of 
sodium azide (Fig. 4). Similar results were seen when cells were exposed to tamoxifen 
and sodium arsenite (data not shown). Therefore, propidium iodide uptake can be used as 
a quick and reliable indicator of cell death.
The Potential Anti-Metastases Drug CAI and the Common Anti-Breast Cancer Drug 
Tamoxifen Inhibited Breast Cell Migration at Non-Cytotoxic Concentrations 
To demonstrate the effectiveness of our assay for measuring anti-migratory and 
cytotoxic properties of drugs, we compared CAI and tamoxifen on a non-tumorigenic and 
a highly metastatic breast cancer cell line. Both tamoxifen and CAI inhibited migration in 
a dose-dependent manner at sub lethal concentrations, and CAI was more effective than 
tamoxifen at halting migration in all cases (Fig. 5). Haptotactic migration on fibronectin 
was more sensitive to drug effects than chemotactic migration towards serum of both cell 
lines (Fig. 5, A-D). MCF-lOA cells exposed to 10 pM CAI demonstrated a 45% 
inhibition of haptotactic migration (Fig. 5C). At 20pM CAI, haptotaxis of these cells was 
completely abolished, and chemotaxis was inhibited 33%. In contrast, lOpM tamoxifen 
inhibited MCF-lOA haptotaxis by only 17%. At 20 pM, tamoxifen abolished haptotactic 
migration of MCF-lOA cells and inhibited chemotaxis by 27% (Fig. 5A). MDA-MB-435 
cells exposed to 10 pM CAI demonstrated 32% inhibition of haptotaxis and 7%
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axis). Error is represented as the standard deviation of 16 wells.
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inhibition of chemotaxis. At 20 pM, CAI abolished haptotaxis and inhibited chemotaxis 
by 42% (Fig. 5D). MDA-MB-435 cells exposed to tamoxifen, however, demonstrated 
non-significant inhibition of chemotaxis and haptotaxis at 10 fiM, and, at 20 pM, only 
51% inhibition o f haptotaxis and 9% inhibition of chemotaxis (Fig. 5B). In addition, 
MCF-lOA cell viability was more sensitive to CAI than MDA-MB-435 cells, as 
evidenced by increased propidium iodide fluorescence (Fig. 5C,D). Vehicle alone 
(DMSO, 95% ethanol) did not significantly affect migration in any case (data not shown).
Discussion
Several screening strategies currently exist for the identification of cytotoxic 
compounds, such as the National Cancer Institute's in vitro anticancer drug discovery 
screen (24). While unregulated cell migration is a nefarious aspect of cancer progression 
and other pathological processes such as arthritic inflammation, no high-throughput 
methods exist to identify inhibitors of cell migration. This is largely because conventional 
migration assays require excessive manipulation that reduces throughput and thus 
precludes them fi*om being used in large-scale screens for anti-migration compounds. In 
addition to the transfilter, modified Boyden chamber assay presented here, other methods 
for measuring cell ntigration include two dimensional assays that measure random, non- 
directional movement on a flat surface and three dimensional migration/invasion assays, 
where cells are seeded into, or allowed to invade a gelatinous matrix. We chose to use the 
transfilter migration assay based on the modified Boyden chamber for ease of use and 
simple determination of migrated vs. non-migrated cells.
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In traditional Boyden chamber filter migration and invasion assays, the migratory or 
invasive cells are fixed, stained, and counted visually under a microscope. In this 
procedure, only representative fields are chosen and counted, a process that introduces 
operator bias. In order to discern migratory from non-migratory cells in these assays, 
non-migratory cells must be physically removed from the upper surface of the membrane. 
Aside from adding extra manipulation into the assay, the assessment may only be 
performed once, and it is difficult to assay viability of the removed cells. Cell 
quantification by fluorescence detection accounts for the fluorescence contribution of 
every cell, thus omitting operator variability. Other protocols for simplifying the 
quantification of migrated cells in a modified Boyden chamber apparatus use markers of 
cell number that are detected after the migrated cells have been lysed. These markers 
include radioactivity o f cell lysate from ^'Cr-labeled cells (25), enzyme activity (26), and 
absorption of a cellular dye (27). Martin et al. (28) have introduced a protocol for 
measuring neutrophil migration that also uses calcien-AM for the r^ id  and sensitive 
detection of migratory cells. While their protocol takes advantage of a high-throughput 
format (Neuro Probe, Gaithersburg, MD), this plate does not have a fluorescence opaque 
filter, thus requiring that non-migratory cells are scraped from the filter before 
quantification. Ours is the only protocol designed for the detection of cancer cell 
migration that incorporates both cell death and migration measurements of the same test 
cell population in the same assay.
Typical plates designed for transfilter migration assays are capable of handling only 
12-24 samples each. Improvements to this design presented in this protocol have made 
the Boyden chamber easier and faster to use. These improvements include increasing the
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numbers of test chambers per plate, decreasing the size of the test chambers, and 
constructing all of the test chambers as one piece, so that all samples per plate can be 
handled simultaneously.
The complexity of signaling cascades regulating migration indicates that many 
different strategies can be exploited to disturb the stimulation of migration. The ability to 
migrate through the tissues of the body is a complicated process involving tissue 
remodeling, directed movement, and arrest at sites of action (1). Aside from being an 
integral aspect of cancer metastasis, cell migration also plays an important role in normal 
cellular processes such as embryonic development, wound healing, angiogenesis, and the 
immune response. Each step is tightly regulated in normal tissues, and involves the 
coordination of signals from extracellular matrix receptors, primarily integrins, and 
growth factor receptors (10,29). The controls regulating cell movement, while 
incompletely understood, are diverse, and vary among cell type. Compounds identified 
by this assay could affect any one of those processes, and identifying the mechanisms of 
action of those compounds could help clarify how cell migration is accomplished.
In this report, we demonstrate that tamoxifen, an anti-estrogen that competes with 
estrogen for binding the estrogen receptor (HR) (30), inhibits migration, and causes cell 
death of estrogen receptor negative (MDA-MB-435) and estrogen receptor positive 
(MCF-lOA) cells. This effect is not surprising since tamoxifen is shown to have an 
alternate mechanism for affecting anti-proliferation and cytotoxicity, besides binding the 
estrogen receptor. In fact, ER negative cancer patients can respond to tamoxifen while 
ER positive patients can be insensitive (31). ER negative breast cells including MDA- 
MB-435 cells have also been shown to respond to tamoxifen in vitro (31, 32).
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The use of a fluorescence blocking membrane suggests the possibility of measuring 
cell migration over time, as opposed to strictly endpoint analysis. We attempted to 
measure the decrease in fluorescence from the top of the filter plate and extrapolate those 
RFU measurements to cell number by comparison to a standard distribution of cells 
contained in wells of the same plate. To achieve this, the cells would have to be pre­
labeled with a bright, stable dye that did not influence cell migration patterns. We 
assessed four classes of live cell fluorescent dyes for these properties, calcein-AM, SP- 
DiOCig(3), CellTracker Blue, and carboxyiate modified fluorescent polystyrene 
microspheres (all purchased from Molecular Probes, Eugene, OR). Calcein-AM is a low 
affinity calcium chelator (23), and inhibits migration of our cell lines, probably by 
interfering with calcium signaling required for migration (data not shown). These data are 
not surprising, as release of calciiun from intracellular stores and opening of calcium 
chaimels in the plasma membrane is a consequence of integrin binding and requisite for 
migration under certain conditions (11,33,34). SP-DiOCig(3) is a lipophilic 
carbocyanine membrane probe that is highly fluorescent when incorporated into cell 
membranes (23). While adhesion and migration are dependent upon membrane integrity, 
we found that SP-DiOC|g(3) did not influence migration and only subtly influenced 
adhesion in our cell lines (data not shown). While this dye showed promise, it exhibited 
less intense emission than calcein-AM and thus produced less sensitive results. In 
addition, while the fluorescence of this dye persisted throughout the migration assay, we 
found fluctuations in emission that interfered with results and were not readily explained. 
These fluctuations could be due to turnover of the cell membrane during the course of the 
assay or inherent limitations of the plate reader. CellTracker Blue is a cell-permeant thiol
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reactive probe thought to produce fluorescent-glutathione adducts (23). This dye lacked 
the emission intensity required for these studies (data not shown). Carboxyiate modified 
fluorescent polystyrene microspheres offer another option for labeling migratory cells in 
a kinetic assay. These microspheres were spontaneously endocytosed and retained in the 
cytoplasm in our cell lines and do not interfere with invasion in vivo (35). In our assays, 
however, carboxyiate rrticrosphere labeling demonstrated poor reliability and sensitivity, 
perhaps by being processed and exocytosed from the cells before completion of the 
migration assay (data not shown). While these dyes are very effective in applications 
such as fluorescence microscopy where individual cells are visualized, they were not 
effective for quantifying large cell populations in kinetic migration assays.
In summary, we introduce a fluorescence based, high throughput assay for screening 
potential anti-migratory compounds. With the use of two fluorescent indicators, this 
assay is designed to discern between cytotoxic and non-cytotoxic mechanisms of action 
of migration inhibiting compoimds. Using this assay, we demonstrated that both the 
experimental anti-cancer compound CAI and the common breast cancer treatment 
tamoxifen inhibited cell migration at sub-cytotoxic concentrations. While MDA-MB-435 
cells showed some resistance to cell death induced by high concentrations of CAI, CAI 
was more effective than tamoxifen at halting migration of both cells lines.
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CHAPTERS
HEAT SHOCK PROTEIN 27 PLAYS TWO DISTINCT ROLES IN CONTROLLING 
HUMAN BREAST CANCER CELL MIGRATION ON LAMININ-5
This chapter has been published in Molecular Cell Biology Research 
Communications and is presented in the style of that journal. The complete citation is:
Rust, W., Kingsley, K.,Petnicki, T., Padmanabhan, S., Carper, S.W., Plopper, G.E. 1999. 
Heat Shock Protein 27 Plays Two Distinct Roles in Controlling Human Breast Cancer 
Cell Migration on Laminin-5. Molecular Cell Biology Research Communications 1, 
pp196-202.
Abstract
It has recently been reported that phosphorylation of the small heat shock protein 27 
(hsp27) enhances p38 MAP kinase dependent migration of bovine and human vascular 
endothelial cells. We have examined the role of hsp27 in controlling the constitutive 
migration of human breast cancer cells on the extra-cellular matrix molecule laminin-5. 
In a haptotaxis assay, anisomycin- or heat shock-induced phosphorylation of hsp27 
enhances migration of MDA-MB-231 breast cancer cells constitutively over-expressing 
hsp27. Under these conditions, hsp27 redistributes to the nucleus. Unphosphorylated 
hsp27, which remains in the cytosol, induces resistance to a subset of drugs that inhibit 
haptotactic migration of these cells. We conclude that hsp27 plays two distinct roles in
49
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controlling migration of breast cancer cells; phosphoiylated hsp27 enhances migration, 
while unphosphorylated hsp27 can sustain migration in the presence of inhibitory drugs.
Introduction
Heat shock protein 27 (hsp27) is a member of the heat shock family of proteins, 
which confer resistance to a variety of cellular stresses (reviewed in 1,2). Hsp27 over­
expression confers resistance to acute heat shock and some anti-cancer drugs (1,3).
Hsp27 function is thought to be controlled by its phosphorylation state and intracellular 
localization, however, the exact mechanism remains unclear.
Following heat shock, hsp27 is phosphorylated and redistributes to the nucleus (1).
This phosphorylation is mediated by mitogen activated protein kinase activated protein 
kinase 2/3, (MAPKAP K2/3) (1), which in turn is activated by upstream kinases ERK 
1/2, JNK/SAPK, and p38 MAPK (2-4). Phosphorylation-deficient mutants do not confer 
heat shock resistance, suggesting that phosphorylation is critical to its ability to protect 
cells from heat (3).
In vitro, hsp27 inhibits actin polymerization (2,3). In vivo, hsp27 complexes are 
sometimes associated with actin filaments in motile cell protrusions such as lamellipodia, 
filopodia, and membrane ruffles (5), suggesting it may play a role in controlling cell 
motility or cytokinesis, though its exact role in these activities is unclear (6,7).
Extracellular matrix (ECM) proteins play a critical role in controlling numerous 
functions in virtually all cells, including migration (8,9). The ECM protein laminin-5 is 
abundantly expressed in the basal lamina of most epithelial tissues, where it promotes 
growth, differentiation, and migration of epithelial cells (10-12). In the breast, laminin-5
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is the preferred adhesive substrate for nonnal breast epithelial cells and mediates 
constitutive migration of breast cancer cells (9). The relationship between hsp27 over­
expression and laminin-5 mediated migration in breast cells has thus far been unexplored.
In the present study, we show that hsp27 over-expression alone does not affect 
constitutive migration of MDA-MB-231 human breast cancer cells towards laminin-5. 
However, phosphorylation of hsp27 by heat shock or MAPK activation enhances this 
migration over control cells, concomitant with its re-localization to the nucleus. In 
addition, unphosphorylated hsp27 confers resistance to drugs that inhibit cell migration, 
and is localized to the cytosol. From these results, we conclude that hsp27 modulates 
migration on laminin-5 by two distinct mechanisms, that can be distinguished by hsp27 
phosphorylation state; phosphorylated hsp27 enhances migration, while 
unphosphorylated hsp27 offers protection against migration inhibitors. These two distinct 
functions may reflect the dual role of hsp27 as an actin polymerization modulator and 
molecular chaperone, respectively.
Materials and Methods
Cells
MDA-MB-231 cells were maintained as previously described (9). DB46 cell line was 
made by transfecting MDA-MB-231 cells with an hsp27 constitutive expression vector 
(p(327), constructed by cloning the human full length hsp27 cDNA (13) fragment into the 
pHpAPr-1 neo (14) under the control of the p actin promoter as previously described 
(15). Control cell line DC4 was made by transfecting cells with the same plasmid lacking 
the hsp27 cDNA sequence.
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Materials
SQ22536, KT5823, H89, Bisindolylmaleimide, Genistein, and Anisomycin were 
purchased from Caibiochem (San Diego, CA). PD98059 was purchased from New 
England Biolabs, (Beverly, MA); and pertussis toxin was purchased from List Biological 
Laboratories, (Campbell, CA). Purified laminin-5 was generously provided by Desmos,
Inc. (San Diego, CA).
Immunoblotting
Cells were scraped and lysed in RIPA lysis buffer, and lysates subjected to western 
blot as previously described (16). In this instance, primary antibodies were anti-hsp-27 
monoclonal antibody (1:1000 dilution), Stressgen, (Victoria BC, Canada) or anti- 
phospho-p44/42 MAP kinase (Thr202/Tyr204) monoclonal antibody (1:2500 dilution). 
New England BioLabs, (Beverly, MA), and alkaline phosphatase conjugated anti-mouse 
monoclonal antibody was used as the secondary antibody.
Quantification o f Apoptosis
Apoptosis was quantified using an ELISA assay kit (Boehringer Mannheim, 
Indianapolis, IN). Briefly, DC4 and DB46 cells were treated with indicated 
concentrations of sodium butyrate for 2 0  hours, then solubilized according to 
manufacturers protocol. ELISA wells were coated with anti-histone antibody, then loaded 
with cytoplasmic extracts, and finally, incubated with anti-DNA secondary antibody 
conjugated with peroxidase. Absorbance of peroxidase substrate was measured at 405nm 
using a Microplate autoreader (Dynatech MR5000).
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Heat Shock Survival
Survival after exposure to 45°C for various time intervals was determined by colony 
forming assay as previously described (17). Briefly, cells were heat shocked at 45®C, 
then allowed to grow for 9-12 days. Colonies (>50 cells) were stained with crystal violet 
and counted. Percent survival is expressed relative to control, unshocked cells.
Transwell Haptotactic Migration Assay
Cell migration was determined as previously described (9) except that cells were 
stained with 5 pM calcein AM, Molecular Probes, (Eugene, OR) added directly to the 
migration wells 30 minutes prior to measuring migration. To quantitate migration, the top 
side of each filter was wiped with a cotton tipped applicator to remove cells that had not 
migrated through the filter, and fluorescence of the incorporated dye was measured from 
the filter with a fluorescence plate reader. Relative fluorescence values for each 
experimental condition are expressed relative to control, untreated samples.
Phosphorylation Assay
Cells were pre-incubated with 100 pCi/ml ^^P-orthophosphate, NEN, (Boston, MA), 
in 90% phosphate-fi’ee medium for four hours, then subjected to either heat or drug 
treatment for 30 minutes. Cells were lysed in RIPA, and 15 pg of cell lysates was 
immunoprecipitated with anti-hsp27 antibody and protein A/G agarose, Santa Cruz 
Biotechnology, (Santa Cruz CA). Immunoprecipitates were separated by SDS-PAGE 
(12% acrylamide), and the dried gel was exposed to film. MAP kinase phosphorylation 
was determined by immunoblotting with monoclonal antibody specific for 
phosphorylated MAP kinase.
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Miscellaneous
Cell adhesion, hnmunoprecipiation, and indirect immunofluorescence assays were 
performed as previously described (16), using anti-hsp-27 monoclonal antibody and anti- 
phospho-p44/42 MAP kinase (Thr202/Tyr204) monoclonal antibody (New England 
BioLabs, Beverly, MA) as primary antibodies where indicated. For affinity captured 
laminin-5 assays, untreated wells were coated with anti laminin-5 monoclonal antibody 
TR-1 (20ug.ml) in lOOmM carbonate buffer (pH 9.3) for one hour at room temperature. 
After washing and blocking with blotto, wells were incubated for 1 hour at room 
temperature with 804G cell conditioned medium, thereby allowing for "capture" of 
soluble laminin-5. Wells were then washed twice with PBST.
Results
The human breast cell line DB46 stably over-expresses hsp27
To examine the effect of hsp27 over-expression on the behavior of human breast 
cancer cells, we stably transfected clones of MDA-MB-231 cells with the pP27 plasmid 
containing full length human hsp27 cDNA under the control of the p-actin promoter 
(15). Overexpression of hsp27 in transfected clones was confirmed by western blot 
(Fig.la), and function of hsp27 in these cells was determined by resistance to sodium 
butyrate-induced apoptosis and heat shock (Fig lb,c). We found that DB46 cells 
expressed 2-3 fold more hsp27 and exhibited increased (10- to 100-fold greater) survival 
when compared to control DC4 cells. From these results we conclude that DB46 cells 
constitutively over-express functional hsp27.
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FIG 1. DB46 cells overexpress hsp27. (A) Western blet for hsp27 in resting (37X) and 
heat shocked (45*’C) DB46 cells transfected with hsp27. As a control, parallel analysis 
was performed on lysates 6 0 m DC4 cells transfected with a control plasmid. Note that at 
both 37*’C and 45*C, DB46 cells contain approximately two- to three-fold more hsp27 
than control cells. (B) Dose response analysis of sodium butyrate-induced apoptosis. 
Note that DB46 cells exhibit four-fold less ^wptosis as measured by ELISA than control 
cells in response to 10 mM sodium butyrate. (C) Dose response anafysis o f % survival o f 
cell colonies following heat shock at 45*C.
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Hsp27 over-expression does not alter binding o f DB46 cells to laminin-5
Because laminin-5 plays a significant role in controlling breast cell growth, 
migration, and difieientiation (8,9), we compared adhesion of DB46 and DC4 cells to 
laminin-5 using 30 minute cell adhesion assays. We fotmd no difference between cell 
lines in adhesion to purified laminin-5 (Fig. 2). Laminin-5 was one of the most preferred 
adhesive substrates compared to additional ECM proteins (Iaminin-1, collagen IV, 
fibronectin).
Phosphorylation o f Hsp27 by MAP kinase enhances migration o f DB46 cells on 
laminin-5
We determined the impact of hsp27 over-expression on haptotactic migration towards 
laminin-5 using in vitro Transwell assays. DB46 cells retained the constitutive migration 
of parental MDA-MB-231 cells on laminin-5, as did control DC4 cells (Fig. 3).
Therefore, hsp27 overexpression alone does not significantly affect migration of DB46 
cells. Under these conditions, hsp27 was weakly phosphorylated in both DB46 and DC4 
cells. However, stimulation of hsp27 by exposure to 4I°C, or via activation of MAP 
kinase with 10 ng/ml anisomycin, led to a significant (29-53%) enhancement of 
migration in DB46 cells (Fig.3a). Under these conditions, both ERK 1/2 and hsp27 were 
phosphorylated, as determined by western blot with anti-phospho-ERK 1/2 antibody (Fig. 
3b) and immunoprécipitation of hsp27 from ^^ P0 4  radiolabeled cells (Fig. 3c). Addition 
of the MEKl (upstream activator of ERK 1/2) inhibitor PD98059 did not significantly 
inhibit migration under normal conditions. These results indicate that hsp27 
phosphorylation by beat or MAP kinase activation enhances migration. While hsp27
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FIG 2. hsp27 overe?q)ressioii does not alter binding of DB46 cells to laminin-5. DB46, 
DC4, and parental MDA-MB-231 cells were plated on the indicated ECM proteins for 30 
minutes, gentfy washed to remove imboimd cells, then fixed, stained, and quantitated as 
described in Materials and Methods. Ln-1= Mouse Iaminin-1, Ln-5 =laminin-5, 
TRl=mouse monoclonal anti-laminin-5 antibody, 804G=conditioned medium fi*om 804G 
cells containing laminin-5. Laminin-5 was captured by affinity method using TRl 
antibody as described in Materials and Methods. Data are presented as statistical mean 
+/- standard deviation ( i^ l6 ).
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FIG 3. Phosphorylation of hsp27 iy  MAP Kinase enhances migration of DB46 cells on 
laminin-5. (A) H^totactic migration assay on laminin-5. During the entire migration 
period, cells were exposed to mild heat slnck (41*C), 10 nM anisomycin, 50 pM 
PD98059. Results expressed as the statistical mean of the mean measurement from each 
filter, +/- standard error o f the means (if=4). (B) Western blot analysis of ERK 1/2 
phosphorylation with anti phospho- MAP kinase antibody. Cells were exposed to the 
indicated conditions for 30 minutes, then lysed and processed for western blot analysis. 
(C) hnmunoprecipiation an a^ is  of phosphorylated hsp27.
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phosphorylation correlated with enhanced migration in DB46 cells, the degree of 
migration enhancement varied with the relative phosphorylation of MAP kinase.
DB46 cells resist a subset o f  migration inhibiting drugs
Hsp27 over-expression confers resistance to drugs that induce apoptosis and inhibit 
growth, possibly by modulating intracellular signaling pathways. To test the hypothesis 
that hsp27 influences laminin-5-associated migration signaling pathways, we repeated 
our cell migration assays in the presence of several drugs that inhibited intracellular 
signaling molecules and reduced migration of parental cells.
We found that DB46 cells were less sensitive to a subset of these drugs than the DC4 
control cells. Specifically, these cells were less sensitive to the migration inhibiting 
effects of pertussis toxin (Ipg/ml), (74% vs. 51% of control migration), which inhibits 
activation of the heterotrimeric G protein subunit Ga,; and completely insensitive to a 
sublethal dose of a specific inhibitor of PKG (KT5823, lOpg/ml), (96% vs. 43% of 
control migration) (Fig. 4). In contrast DB46 cells were equally sensitive to inhibitors of 
adenylate cyclase (SQ22536,50pM), protein kinase A (H89, lOpM), protein kinase C 
(bisindolylmaleimide, lOpM) and protein tyrosine kinases (genistein, 50pM) (Figure 4). 
Thus, hsp27 protection under these conditions is not broadly applied but specific to 
certain signaling pathways involving at least PKG and Gai.
The hsp27 that confers resistance to migration inhibiting drugs is unphosphorylated 
Because hsp27-enhanced migration of DB46 cells is phosphorylation-dependent, we 
determined the phosphorylation state of hsp27 under conditions where it conferred 
resistance to migration inhibiting drugs. Identical concentrations of drugs used to inhibit 
migration were administered to ^^P0 4 -labeled cells for 30 minutes, and hsp27
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FIG 4. DB46 cells resist a subset of migration-inhibiting drugs. Migration assays were 
performed as in Figure 3, except that cells were plated in the presence of indicated 
concentrations of inhibitory drugs. Results expressed as the statistical mean of the mean 
measurement from each filter, +/- standard deviation (n=4).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
61
phosphorylation was determined by immunoprécipitation and autoradiography. Except 
for modest phosphorylation by bisindolylmaleimide, no drug treatment induced hsp27 
phosphorylation over background levels (Fig. 5). These results demonstrate that hsp27 
plays two discrete roles in controlling migration in DB46 cells: unphosphorylated hsp27 
protects against the migration-inhibiting effects of pertussis toxin and KT5823, while 
only phosphorylated hsp27 enhances MAP kinase-dependent migration. Percent 
migration relative to control (37°C, no drugs) is indicated above band for each treatment. 
Enhancement o f migration by phosphorylated hsp27 correlates with its relocalization to 
the nucleus
Phosphorylation o f hsp27 can affect its intracellular localization (18). Because we 
observed that hsp27 phosphorylation distinguished between its migration-enhancing or 
drug resisting effects, we determined its subcellular localization under both conditions. 
Indirect immunofluorescence microscopy revealed that, in the absence of heat shock or 
drug treatments, hsp27 was distributed throughout the cytosol with a slight concentration 
in the perinuclear region (Fig. 6 , panel B). Upon heat stimulation or treatment with 
anisomycin, hsp27 relocated to the nucleus within 45 minutes (Fig. 6 , panels F,H). In 
contrast, hsp27 did not relocalize in cells treated with pertussis toxin (Fig. 6 , panel D).
From the above data, we conclude that hsp27 plays two distinct roles in controlling 
migration of DB46 cells on laminin-5: when phosphorylated, hsp27 concentrates in the 
nucleus and enhances constitutive migration, while unphosphorylated hsp27 remains 
distributed throughout the cytosol and offers resistance to a subset of signaling inhibitors 
that reduce constitutive migration.
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FIG. 5. Correlation of migration to hsp27 phosphorylation state. Percent migration data 
(above) obtained from figures 3a and 4. Immunoprecipiation analysis of phosphorylated 
hsp27 performed as described in materials and methods using anti hsp27 Ah.
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FIG. 6 . Localization of hsp27 and f-actin. Fluorescence micrographs of DB46 cells 
doubty stained for actin (phalloidin) and hsp27. Magnification = 400X.
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Discussion
Our data present three lines of evidence that hsp27 acts in two distinct roles to affect 
cell migration. First, activation of MAP kinase cascades by anisomycin leads to 
phosphorylation of hsp27 and enhanced migration. While overexpression of hsp27 can 
enhance cell migration in a phosphorylation dependent manner (19), the upstream 
signaling mechanisms responsible for mediating this effect are not well defined. In 
endothelial cells, p38 and SAPK2, but not ERK 1/2, mediate hsp27-dependent 
modulation of the actin cytoskeleton and chemotactic migration (4,20,21). However, the 
MAP kinase ERK 1/2 is implicated in ECM mediated events and may be involved in 
haptotactic migration on laminin-5 (22). Inhibition of ERK 1/2 by PD980S9 did not 
inhibit haptotactic migration on laminin-5, though it's phosphorylation by anisomycin did 
correlate with enhanced migration. This result does not rule out the involvement of p38 
and SAPK, both of which are activated by anisomycin (23).
Second, unphosphorylated hsp27 offers protection against inhibitors of specific 
intracellular signaling molecules in our cells. Hsp27 selectively protects against cytotoxic 
compounds, some of which stimulate intracellular signaling cascades (24, 25), perhaps by 
acting as a molecular chaperone (24); this protection is not always phosphorylation 
dependent (26). In our cells, hsp27 confers resistance to the repression of migration by 
inhibitors of PKG and adenylate cyclase, but not inhibitors of PKA and PKC. These 
results raise the possibility that hsp27 may function as a molecular chaperone or signaling 
molecule to maintain activity of a subset of signaling pathways required for constitutive 
migration of malignant tumor cells.
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Third, hsp27 redistributes to the nucleus and sites of actin polymerization when 
phosphorylated, and remains cytosolic when unphosphorylated. This differential 
distribution correlates with the two distinct functions we observe in our cells, 
enhancement of migration, and protection against signaling inhibitors. Others have 
reported similar changes in distribution of hsp27 in response to serum stimulation (2,18), 
although re-localization in response to heat shock may be independent of hsp27 
phosphorylation (5).
In summary, the most significant finding of this study is that hsp27 affects migration 
of breast cancer cells by two distinct mechanisms. Further, these mechanisms can be 
distinguished on the basis of hsp27 phosphorylation state and intracellular localization. 
Because hsp27 is thought to act as a molecular chaperone, our data support a model 
whereby unphosphorylated hsp27 sequesters damaged signaling molecules, thereby 
conferring resistance to drugs that otherwise inhibit haptotactic migration of breast cancer 
cells. Because phosphorylated hsp27 functions as an actin capping protein in vitro (4), 
this may explain why it enhances constitutive migration of breast cancer cells; In our 
model, phosphorylation of hsp27, coupled with a haptotactic migration stimulus (e.g., 
binding to ECM proteins such as laminin-5), may enhance actin filament assembly within 
the leading edge of migrating cells.
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CHAPTER 4
ANTIBODY INDUCED ACTIVATION OF pi INTEGRIN RECEPTORS 
STIMULATES cAMP-DEPENDENT MIGRATION OF 
BREAST CELLS ON LAMININ-5
This chapter has been published in Molecular Cell Biology Research 
Communications and is presented in the style of that journal. The complete citation is:
Plopper, G.E., Huff, J.L., Rust, W.L., Schwartz, M.A., Quaranta, V. 2000. Antibody 
induced activation of pi integrin receptors stimulates cAMP-dependent migration of 
breast cells on laminin-5. Molecular Cell Biology Research Communications 4, ppl29- 
135.
Abstract
The pi integrin-stimulating antibody TS2/16 induces cAMP-dependent migration of 
MCF-lOA breast cells on the extracellular matrix protein laminin-5. TS2/16 stimulates a 
rise in intracellular cAMP within 20 minutes after plating. Pertussis toxin, which inhibits 
both antibody-induced migration and cAMP accumulation, targets the Gai3 subunit of 
heterotrimeric G proteins in these cells, suggesting that Gai3 may link integrin activation 
and migration via a cAMP signaling pathway.
70
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Introductioii
Laminins are a diverse group of heterotrimeric extracellular matrix proteins that 
constitute a major component of the basement membrane of epithelial tissues. The 
laminin-5 isoform, consisting of the o3, p3 and y2 subunits, is abundantly expressed in 
the basement membrane of breast tissue [1] where it plays a role in mammary branching 
morphogenesis, and adhesion and migration of breast epithelial cells [2 ].
Evidence from both in vitro and in vivo studies support a frmctional role for laminin-5 
in cell migration of both normal and malignant breast epithelial cells. Our laboratory has 
previously shown that in vitro, laminin-5 is the preferred adhesive substrate for breast 
epithelial cells [1]. In haptotactic migration assays, non-tumorigenic breast cell lines fail 
to migrate significantly on laminin-5, whereas laminin-5 supports migration of highly 
malignant breast cell lines. In vivo, laminin-5 expression is enhanced in invading regions 
of metastatic breast tumors[3j. In addition, an altered conformation of laminin-5, 
resulting from proteolytic cleav%e of the y2 chain by matrix metalloprotease 2 , is found 
at sites of tissue invasion, and this cleavage stimulates migration of otherwise non­
migrator) breast cells in vitro [4]. Laminin-5 may contribute to the progression of 
tumorigenic breast cells from the stationary to malignant phenotype by stimulating 
enhanced migration of these cells.
Cells interact with laminins primarily through integrin receptors [5]. Ligand induced 
signal transduction by integrin/laminin binding regulates intracellular pH, tyrosine 
phosphorylation, inositol lipid metabolism, and calcium (Ca^^ oscillations [6 ]. Signaling 
molecules known to associate with integrins receptors include protein tyrosine kinases, 
serine/threonine kinases, phospholipid kinases and lipases, ion channels, and members of
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the rho family of small molecular weight GTP binding proteins [6 ]. Laminin-5 is 
recognized by the aSpl, a 6 pi and a6p4 integrin receptors in a number of cell types, and 
the functional consequence of these interactions depend on the integrin receptor engaged. 
For example, ligation of laminin-5 with the «6^4 integrin receptor supports branching 
morphogenesis and hemidesmosome formation in breast epithelial cells [2 ], while 
interaction with o3P 1 integrin supports migration of these same cells in vitro [7]. Little 
information is currently available on the specific signaling pathways triggered during 
these events.
While investigating the role of the a3p 1 integrin in motility of breast epithelial cells, 
we observed that haptotactic migration of the immortalized breast epithelial cell line 
MCF-lOA on laminin-5 was stimulated by direct activation o f the p i integrin receptor 
with the pi-activating monoclonal antibody TS2/16. Migration was dependent on 
intracellular cAMP signaling, and TS2/16-promoted a rise in intracellular cAMP levels 
that occurred 20 minutes after plating on laminin-5. Migration and cAMP accumulation 
were inhibited by treatment of the cells with pertussis toxin, a compound that inactivates 
the a  subunit of the inhibitory class of heterotrimeric G proteins via ADP-ribosylation.
We show that the Gai3 isoform is a target for ribosylation by pertussis toxin in these 
cells. Together these data present evidence that the pi integrin participates in the 
regulation of MCF-lOA cell migration on laminin-5 through a cAMP-signaling pathway 
involving Gai3. This is the first description linking integrin activation to signaling 
through heterotrimeric G proteins.
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Materiab and Methods
Cells
MCF-lOA cells were maintained in DFCI medium according to Band and Sager [8 ]. 
MDA-MB-231 cells were cultured as described [1]. Rat 804G cells were maintained in 
Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal calf serum and IX 
Glutamine Pen-Strep solution (Irving Scientific). 804G cell conditioned medium was 
collected after 3 days of culturing and was clarified by centrifugation at 1500 x g.
Reagents
Mouse monoclonal antibodies against human integrin o3 (clone P1B5) and PI (Clone 
P4C10) were purchased from Gibco (Gaithersburg, MD). Mouse monoclonal antibody 
clone P5D2 against human pi integrin was purchased from Chemicon (Temecula, CA). 
Purified rat anti-mouse pi antibody 9EG7 was purchased from Pharmingen (San Diego, 
CA), and dialysed against PBS to remove sodium azide. Mouse monoclonal anti-human, 
activating pi integrin antibody TS2/16 (in ascites form) was generously provided by Dr. 
Martin Hemler (Dana Farber Cancer Institute, Boston, MA). Anti-rat laminin-5 
monoclonal antibody TRl was produced in-this laboratory [9]. Both TS2/16 and TRl 
were purified with a protein G affinity chromatography kit (Pierce, Rockland IL).
SQ22536 was purchased from Biomol (Plymouth Meeting, PA) and pertussis toxin from 
List Biological Laboratories, Inc. (Campbell, CA). 8 -Bromo-cAMP, dibutryl cAMP, H- 
89, and forskolin were purchased from Calbiochem (San Diego, CA).
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Adhesion and migration assays
Adhesion and migration assays were performed as previously described [I]. For anti- 
integrin antibody blocking experiments, antibodies were incubated with cells for 30 
minutes before adding to assay wells, and were present throughout the assays. 
cAMP determination
Cells were collected by brief trypsinization, blocked with trypsin inhibitor, washed in 
DMEM, counted, resuspended at 1 x 10^  cells/ml, and incubated at 37°C in migration 
mediiun/1 mM isobutylmethylxanthine (Sigma) to block phosphodiesterase activity.
After 30 minutes, anti-integrin antibodies (TS2/16 or P5D2) were added, and cells were 
incubated at 37°C for an additional hour. Control cells were suspended in DMEM/1 mM 
isobutylmethylxanthine alone during this time. Cells (1 x 10^/plate) were then plated on 
35 mm dishes coated with affinity-captured laminin-5 [1] and incubated at 37°C for the 
indicated times. Cells representing the 0 time point were immediately retrieved from the 
dishes, collected by centrifugation, and lysed in cold cAMP extraction solution (95% 
ethanol, 5% 0.1 N HCI). After 10,20,30, and 90 minutes non-adherent cells were 
aspirated, plates were washed with PBS, and cAMP extraction buffer was added to the 
adherent cells. The PBS washes firom each plate were centrifuged to collect loosely 
adherent cells, and these were added back to the appropriate extraction. All samples were 
kept on ice in cAMP extraction buffer for 2 hours, then centrifuged to pellet precipitated 
protein. Protein was dissolved in 0.1 N NaOH and concentrations were determined with 
the BCA microassay (Pierce). Supemantants were evaporated and cAMP measured using 
a cAMP EIA kit (Perseptive Diagnostics, Inc., Cambridge MA) as directed by the
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manufacturer. cAMP amounts were normalized to total protein in each sample and 
expressed as finol/pg protein.
ADP ribosylation assay
Membranes were isolated from MCF-lOA cells by lysis in ice-cold 10 mM HEPES 
pH 7.5,3 mM MgCh, 2 mM EDTA containing 10 pg/ml leupeptin, 2 pg/ml aprotinin, 
and 0.5 mg/ml Pefabloc SC (Boehringer Mannheim Biochemicals, Indianpolis, IN).
Cells were scraped, centrifuged to pellet nuclei, and the supernatant was collected. 
Membranes were pelleted from supernatant by centrifugation at 13,000 x g for 30 
minutes at 4°C; and the pellets were resuspended in lysis buffer. Protein concentrations 
were determined by BCA protein assay (Pierce).
ADP-ribosylation and Immunoprécipitation:
ADP-ribosylation reactions were performed as described [10]. Final reaction 
conditions were as follows: lOOpg membrane protein was suspended in 20 mM 
thymidine, 1 mM ATP, 1 mM GTP, 1 mM EDTA, 20 mM HEPES, pH 7.5 with or 
without 7.5 pg pertussis toxin (activated prior to experiment by incubation for 10 minutes 
at 37°C in 20 mM DTT, 20 mM HEPES, pH 7.5) and 25 pCi ^^P-NAD (Specific activity 
= 30 Ci/mM, New England Nuclear catalog # BLU023). Reactions proceeded for 45 
minutes at 30®C and were stopped by chilling to 4°C followed by a wash with 20 mM 
HEPES pH 7.5,1 mM EDTA and 1 mM DTT. For SDS-PAGE analysis, membranes 
were solubilized in 50 pi Laemmli sample buffer (LSB), heated for 5 minutes at 100“C 
and separated on a 12% SDS-polyacrylamide gel. ^^P-labeled proteins were detected by 
autoradiography of dried gels using Kodak X-Omat AR film with intensifying screens.
For immunoprécipitations, ribosylated membrane proteins were solubilized in RIPA
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buffer containing protease inhibitors and were incubated with the following G-protein a  
subunit-specific peptide antibodies: 1-20, specific for God-1; C-10, specific for God-3 
(Santa Cruz Biotechnology). Immune complexes were captured by incubation with A/G 
agarose (Santa Cruz Biotechnology), solubilized by boiling in LSB and analyzed by 
SDS-PAGE as described.
Results and Discussion
The p i integrin activating antibody TS2/16 stimulated MCF-lOA migration on laminin-5 
The non-tumorigenic breast cell MCF-lOA remains statically adherent to laminin-5 
via the oc3pi integrin [1]. In haptotactic Transwell filter migration assays, these cells 
demonstrated only modest migration towards laminin-5. When pre-incubated with 
TS2/16, however, MCF-lOA cells increased their migration in a dose-dependent maimer 
towards laminin-5 (Fig 1). TS2/16-treated cells also exhibited increased adhesion to 
laminin-5 (Fig. 2). These effects are not observed with other pi targeting antibodies 
(P5D2,9EG7, Fig. 1; 9EG7, Fig. 2) or with TS2/16 on other substrates (data not shown). 
TS2/16 therefore stimulated a signaling pathway that, concurrent with laminin-5 binding, 
led to enhanced cell migration. This pathway is dependent upon binding of the a3p i 
integrin, as pretreatment of the cells with the a3 integrin-blocking antibody P1B5 
completely blocked TS2/16-stimulated migration on laminin-5 (Fig 1).
In each experiment, maximum stimulation of cell migration was observed when cells 
were allowed to migrate towards a gradient of fetal calf serum. This control was included 
in each migration assay to indicate the dynamic range of migration response in each 
population of cells. It is likely that this chemotactic migration was stimulated by the
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FIG. l.The integrin activating antibody TS2/16 stimulates migration of MCF-lOA breast 
cells on laminin-5. Indicated concentrations of TS2/16 were added to MCF-lOA cells in a 
minimal medium lacking serum or other growth foctors (MM) 15 minutes prior to plating 
in laminin-5 migration assays, and migrated cells were counted 18 hours hier. As 
controls, cells were plated in the presence of 10% serum, irrelevant mouse ascites (FM3 
ascites), antibody purified from irrelevant ascites (FM3 pure), or non-frt dried milk 
(blotto). Results are expressed as the mean of eight measurements on two filters using 
300 X m^nification, +/- standard deviation.
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FIG. 2. TS2/16 antibody increases adhesion of MCF-lOA cells to laminin-S. Cells were 
incubated in MM with 50 pg/ml of TS2/16 or 9EG7 antibodies for 15 minutes, then were 
plated on aflSnity-captured laminin-5 for 30 minutes and adhesion quantified by 
measuring absorbance of crystal violet-dyed cells at 595 nm. AfBnity capture was 
accomplished by successive addition of indicated concentrations o f TRl antibody, blotto, 
and 80i4G-conditioned medium containing soluble laminin-5. As a control (CTL), cells 
were incubated with no antibodies prior to plating. Results «q)ressed as statistical mean 
+/- standard deviation ( i^ 8 ).
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growth factors present in fetal calf serum, as serum-induced migration was inhibited by 
greater than 80% Wien cells were preincubated with antibodies that block the function of 
the epidermal growth factor receptor or drugs that inhibit tyrosine kinases (G.E. Plopper, 
unpublished data). It is therefore likely that serum was a stronger pro-migratory stimulant 
than TS2/16 because it activated several signaling pathways stimulated by soluble growth 
factors, while TS2/16 targeted integrin-associated signaling pathways.
The strength of cell adhesion to extracellular matrix ligands varies over a wide range, 
and is under the control of both intracellular and extracellular cues. Work by 
Lauffenburger [11] suggests that very tight or very loose cell adhesion to matrix proteins 
will not support cell migration, and that migration occurs only when a medium-strength 
of adhesion is achieved. Thus, varying the potency of adhesion of integrin receptors for 
their ligands may be a critical step for regulating cell migration. It is possible that TS2/16 
stimulated migration in these cells by changing the strength of adhesion between aSpi 
integrin and laminin-5, either directly or via activation of internal signaling pathways.
Alternatively, it is plausible that TS2/16 induced a conformational change in the p I 
integrin that mimicked binding to a pro-migratory form of laminin-5, such as those 
created through proteolytic processing. For example, cleavage of the 72 subunit of 
laminin-5 creates a conformation on which MCF-lOA cells migrate constitutively [4,12].
A pro-migratory laminin-5 can be converted to one that inhibits cell migration through 
cleavage of the a3 chain [13]. In both instances it is assumed that proteolytic processing 
masks or unmasks a pro-migratory domain on the intact laminin-5 trimer. This theory is 
also supported by studies showing that integrin activation by TS2/16 will rescue the 
growth of MCF-lOA cells inhibited by treatment with laminin-5 blocking antibodies [14].
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MCF-lOA cell migration on laminin-5 is modulated by cAMP
To define the mechanisms by which TS2/16 stimulated MCF-lOA cell migration on 
laminin-5, we added inhibitors of known signaling molecules to antibody-stimulated cells 
in h^totaxis migration assays. We found that SQ22536, an inhibitor of adenylate 
cyclase, and H-89, an inhibitor of cAMP dependent protein kinase, completely blocked 
TS2/16 stimulated migration on laminin-5 (Fig. 3). In addition, pharmacological 
enhancement of cAMP levels with either forskolin or the non-hydrolygable cAMP 
analogs 8 -bromo-cAMP and dibutyryl cAMP were sufficient to enhance migration of 
MCF-lOA cells on laminin-5 to levels stimulated by TS2/16 (Fig. 3). Prolonged (18 hour) 
exposure to pertussis toxin, a compound that inhibits the cAMP signaling pathway 
mediated by the Gai class of signaling proteins, abolished migration on laminin-5 (Figure 
4) and reduced cAMP levels in MCF-lOA cells over the same time course (Figure 5B). 
These data established that cAMP was required for enhanced migration of MFC-lOA 
cells on laminin-5.
Because adenylate cyclase activity is governed by different classes of heterotrimeric 
G proteins we exposed MCF-lOA cells to pertussis toxin (an inhibitor of the Gai class) 
and cholera toxin (an activator of the Gas class). While both pertussis and cholera toxin 
partially blocked serum stimulated migration of MCF-lOA cells (approximately 50%), 
only pertussis toxin blocked TS2/16 stimulated migration on laminin-5 (Fig. 4). These 
data demonstrated that the specific pathway triggered by TS2/16 and laminin-5 was 
susceptible to regulation by Gai rather than Gas proteins, and again suggest that serum- 
stimulated migration resulted firom activation of multiple signaling pathways, some of 
which utilize cAMP as a second messenger.
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FIG. 3. Enhanced cAMP levels induce migration of MCF-lOA cells on laminin-5. Cells 
were incubated in MM supplemented with 50 pg/ml TS2/16,50 pg/ml P1B5,250 mM 
SQ22536 (SQ), 4 pM H89, 5 nM forskolin (FSK), 500 pM dibutyryl cAMP (db cAMP), 
or 500 pM 8-bromo-cAMP (8 -Br-cAMP) for 15 minutes prior to adding to laminin-5 
migration assays. As a control, cells were plated in the presence o f serum or in MM on 
filters lacking laminins (blotto). Results are expressed as in Fig. 1.
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FIG. 4. Pertussis toxin inhibits TS2/16-stimu]ated migration on laminin-5. MCF-lOA 
cells were suspended for 30 minutes in MM supplemented with either 10% serum or 50 
pg/ml TS2/16.100 ng/ml pertussi toxin (PT), 100 ng/ml cholera toxin (PT), were added 
15 minutes prior to plating cells in laminin-5 miration assays. As a control, cells 
suspended in MM were added to filters coated with blotto alone. Results expressed as in 
Fig. I.
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FIG. 5. Pertussis tcxin inhibits a cAMP peak in TS2/16-stimulated cells. MCF-lOA cells 
were suspended in MM supplemented with 20 pg/ml TS2/16 or P5D2 antibodies and 
plated on laminin-5 for the indicated time, then lysed and assayed for total cAMP content 
by ELISA assay. As a control, cells were plated in the absence of antibodies (CTL). The 
experiments were performed (A) in the absence (-PT) or (B) presence (+PT) of 100 ng/ml 
pertussis toxin. Results are normalized to total cell protein for each time point and 
represent the mean of triplicate measurements for four experiments, +/- the standard error 
of the means.
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Not all compounds that induced a rise in cAMP stimulated migration on laminin-5. 
Cholera toxin induced a transient rise in cAMP in MCF-lOA cells (G.E. Plopper, 
unpublished observations), and stimulated growth of these cells when used in small 
quantities (ng/ml) in the low-serum media for these cells (DFCI medium) [8 ]. It is 
generally thought that small quantities of cholera toxin stimulate growth in these cells by 
activating signaling pathways used by G protein-linked chemokines (Gary Bokoch, 
Department of Immunology, The Scripps Research Institute, personal communication). 
Higher concentrations of cAMP (pg/ml) typically used to irreversibly activate Gas did 
not stimulate haptotactic migration of MCF-lOA cells on laminin-5 (G.E. Plopper 
unpublished observations), suggesting that while cholera toxin does afTect signaling in 
these cells, the pathways it affects do not play a role in integrin activated migration on 
laminin-5.
Chemotactic migration o f many cell types is inhibitable by cholera and pertussis 
toxins [15,16]. While pertussis toxin allows for unchecked cAMP production in the short 
term, prolonged pertussis toxin exposure suppressed cAMP levels in our cells, likely 
because of long-term desensitization of this pathway [17]. Although O’Conner et al. [18] 
reported that a6p4 expression suppressed cAMP levels in migrating breast cancer cells, 
no evidence has been published linking cholera and pertussis-sensitive signaling 
pathways to integrin-activated signaling.
These findings are consistent with our observation that numerous chemokines that 
modulate cAMP through G as (bombesin, bradykinin, adrenaline) raised cAMP levels but 
failed to stimulate migration in our cells (G.E. Plopper, unpublished data). Each of these 
compounds exerts very distinct responses in breast cells, suggesting that while they share
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c AMP as a second messenger, they must generate specificity elsewhere in their signaling 
pathways. The specificity necessary to modulate haptotactic migration may be generated 
by localizing cAMP bursts to specific times and/or locations within a cell, by targeting 
specific isoforms of adenylate cyclase, or by integrating cAMP bursts with other integrin- 
associated behaviors (e.g, formation of focal adhesions, generation of cellular tension, 
activation of signaling pathways linked to migration in other cell types [e.g., those that 
utilize rho/ras G proteins or focal adhesion kinase]) [19].
Indeed, such integration appears to take place in smooth muscle cells, which exhibit 
increased migration on collagen upon activation of a cAMP signaling pathway linked to 
integrin associated protein and o 2 p i integrin; this activation also stimulates the mitogen 
activated protein kinase ERK, and is inhibited by pertussis toxin. [20]. In this study, 
migration is stimulated upon a reduction in cAMP levels and is inhibited by analogs of 
cAMP. The differences between these findings and ours may be attributed to differences 
in cell type, migratory stimulus, migratory substrate, and/or integrin receptor involved: 
we have observed that inhibition of o 2 pi integrin stimulates haptotactic aSpi-mediated 
migration in our cells, for example (G.E. Plopper, unpublished findings).
TS2/16 stimulated a rise in intracellular cAMP via a pertussis toxin-sensitive signaling 
pathway
Since pertussis toxin alters intracellular cAMP levels, and cAMP modulation was 
sufficient to enhance migration in our cells, we examined the levels of cAMP in TS2/16- 
stimulated cells plated on laminin-5. Within 20 minutes after plating, cAMP levels were 
raised approximately four-fold in TS2/16 treated cells. This peak occurred within the 
time firame of integrin signaling [6 ]. Enhanced cAMP accumulation was specific to
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TS2/16, and not a product of integrin clustering, as neither cells treated with the non­
activating pi antibody P5D2 nor cells plated on laminin-S without antibodies exhibited 
enhanced cAMP production (Figure 5A). Pre-incubation with pertussis toxin completely 
eliminated this peak but did not significantly affect basal cAMP levels (Figure SB). 
Concurrent stimulation by laminin-S adhesion and TS2/16 are required, as cAMP levels 
did not change in suspended cells treated with TS2/16 (G.E. Plopper, unpublished). It 
appeared, therefore, that the combination of intact laminin-S and TS2/16 pretreatment 
stimulated a signaling pathway involving cAMP that was specifically blocked by 
pertussis toxin.
Pertussis toxin ADP-ribosylated Gcd3 in MCF-lOA cells
Pertussis toxin ADP ribosylates the Gai class of heterotrimeric G proteins. To 
determine the repertoire of Gai subunits expressed in MCF-lOAs we performed Western 
blot analysis of whole cell lysates and isolated membrane fractions using polyclonal 
antibodies raised against specific G protein subunits. These studies revealed that MCF- 
lOA cells expressed Gail and Gai3, but not Gai2 (data not shown). To establish the 
targets of pertussis toxin in these cells we carried out ADP-ribosylation assays in the 
presence of^^P-NAD. Addition of pertussis toxin specifically induced the ribosylation of 
a 43 kDa protein (Fig. 6 , lane 2). No ^^ P labeled proteins are detectable without addition 
of pertussis toxin (Fig. 6 , lane 1). The molecular weight of the ribosylated protein was 
consistent with that of the a  subunits of heterotrimeric G proteins. The identity of this 
protein was determined by immunoprécipitation of the ribosylated membrane proteins 
with Gail and Gai3 antibodies. Antibody CIO, which reacts primarily with Gai3, 
immunoprecipitated a band of 43 kDa (Fig. 6 , lane 4). The anti-Gail antibody 1-20 failed
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FIG. 6 . Pertussis toxin specifically ADP ribosylates Goi3 in MCF-lOA cells. 100 pg of 
cell membranes were incubated with 25 pCi ^^P-NAD in the presence (lanes 2-4) or 
absence (lane 1) of 7.5 pg activated pertussis toxin. Pertussis toxin-treated lysates were 
immunoprecipitated with anti-Gail ^-20, lane 3) or anti-Goi3 (CIO, lane 4) antibodies. 
As a control, Gail was immunoprecipitated fi’om ^^P-NAD labeled lysates of pertussis 
toxin-treated MDA-MB-231 cells ( CTL, lane 5). Nfigration of molecular w ei^t 
standards is shown at left.
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to precipitate any ADP ribosylated proteins in MCF-lOA ceils (Fig. 6 , lane 3), but did 
precipitate a 43 kDa band from a control cell line, MDA-MB-231 (Fig 6 ., lane 5). 
Therefore, pertussis toxin ribosylated Gai3, but not Gail in MCF-lOA cells.
In addition to controlling adenylate cyclase activity, Gai3 is associated with and 
activates amiloride-sensitive Na^ channels [2 1 ], which are expressed in many epithelial 
cells including breast. These channels are also regulated by the actin cytoskeleton [22] 
and cAMP dependent protein kinase [23], suggesting that Gai3 may link integrin- 
mediated actin polymerization, cAMP signaling, cAMP dependent protein kinase 
activity, and amiloride-sensitive channel activation. Curiously, amiloride also suppresses 
lung métastasés from breast tumors [24]; our data suggest that it may do so, at least in 
part, by inhibiting tumor cell migration.
In conclusion, we report that the p i integrin-stimulating antibody TS2/I6 induced 
migration of MCF-lOA cells on laminin-5 that was dependent upon cAMP linked 
signaling. TS2/16 also stimulated a rise in intracellular cyclic AMP within 20 minutes 
after plating on laminin-5. Both the enhanced migration and cAMP peak were inhibited 
by pertussis toxin. Pertussis toxin targeted the Gai3 subunit of heterotrimeric G proteins 
in these cells. This evidence suggests that the pi integrin participates in the control of 
MCF-lOA cell migration on laminin-5 via a cAMP signal pathway regulated by Gai3.
This form of signaling, beginning with an external stimulus of the integrin receptor, is 
referred to as “outside-in signaling” to differentiate it from changes in integrin function 
resulting from activation of internal signaling pathways [6 ]. We propose that TS2/16 
mimics the effects of proteolytic processing of laminin-5 by forcing the a3p i integrin 
into a conformation formed by binding pro-migratory forms of laminin-5. We are
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currently examining the effect of these proteolytic modifications on intracellular 
signaling activities in MCF-lOA cells. Because acquisition of a migratory phenotype is 
required for malignant progression of tumorigenic breast cells, elucidating pathways 
involved in enhanced migration of breast may lead to discovery of novel targets for 
anticancer therapies.
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CHAPTERS
LAMININ-1 DOMAINS AS SPECIHC ACTIVATORS OF 
INTEGRIN SUBTYPES
Abstract
Cells interact with laminin-1 with as many as six different integrin heterodimers.
Here I have identified integrins a 6 pl, a ip i  and potentially a3pi as laminin-1 receptors 
used by MCF-lOA cells. I hypothesize that MCF-lOA cell response to laminin-1 
engagement is a product of the cumulative effect of engagement of all three integrins, 
stimulating at least two separate intracellular signaling cascades. To test this hypothesis, I 
identified intracellular calcium flux as a downstream marker of integrin signaling 
response, and demonstrated that clustering of independent integrins and different integrin 
ligands stimulate unique intracellular calcium fluxes. In order to gauge the impact o f each 
integrin on calcium flux, I constructed six fiagments of laminin-1 in a baculovirus system 
that likely contained integrin binding sites. Each of these were screened for the ability to 
act as adhesive substrates for MCF-lOA cells. My results indicate that recombinant 
domains of laminin produced by this method are not suitable integrin ligands.
93
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Introduction
It is tempting as a researcher to fit biological molecules into linear cascades of 
specific function. It is becoming more and more evident, however, that most molecules, 
especially those involved in signaling, are components of a balancing act between 
intracellular events whose ultimate outcome can only be predicted by observing the net 
influence of intracellular conditions within a specific time frame. For example, Ras is 
recognized as a molecule that promotes cell growth via MAP kinase stimulation. In the 
absence of PI-3 kinase, or NF-kB activation, Ras stimulation results in the opposite 
effect, apoptosis [1]. It can therefore be postulated that specific function can not be 
attached to particular molecules without taking into account other cellular conditions. In 
order to gain a true understanding of integrin function, the same paradigm must be 
applied.
To date, a great number of signaling cascades (kinase activation, phospholipid 
metabolism, small and large G-proteins, ion current, intracellular pH) and cellular 
functions (proliferation, death, migration, embryogenesis, gene transcription and protein 
secretion) have been attributed to integrin activation. Since a cell will engage its matrix 
ligand with only a few integrin subtypes, it is impossible to rationalize the specificity of 
cellular outcomes based on linear, single-function signal cascades. The hypothesis 
proposed here is that the consequence of integrin ligation is an emergent property 
dependent upon the activation state of all expressed integrins. The specificity of integrin 
function is a result of cooperative balance between integrin stimulated signal cascades.
For this hypothesis to be reasonable, integrins with common substrate specificity 
must be capable of stimulating different signal cascades, and must be able to
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communicate by signai cascade overlap. As an example of similar integrins sending 
different signals, integrins bound to collagen type IV can either stimulate or inhibit RhoA 
activity depending on the specific integrins engaged, and time course of engagement [2 ]. 
There are several examples in support of the integrin communication by signal cascade 
overlap. Certain epithelial cells adhere strongly to laminin-5 via a 6 pi, and weakly to 
laminin-1, where both aSP I and a 6 pi are engaged. Microinjection of the o3 cytodomain 
disrupts a 6 pi mediated adhesion to laminin-1, indicating that o3pi transdominantly 
regulates a 6 pi activity [3]. This communication by integrin receptors is also 
demonstrated in the regulation of phagocytosis and migration by macrophages [4]. In this 
case, avp3 blocks a5pi function through inhibition of CaMKII. In myocardial muscle 
cells, transfection with integrin a7  stimulates cell adhesion to laminin-1, but inhibits the 
ability of native aS to bind to fibronectin [5].
In order to understand how these emergent properties of integrins are achieved, it is 
necessary to be able to stimulate individual integrin subtypes alone and in combination, 
across a variety of cell types. For this I chose to produce recombinant fragments of the 
likely integrin binding domains of laminin-1, and screened those for the ability to bind 
one, and only one integrin subtype. Laminin-1 was chosen because it is recognized by six 
integrin subtypes (a ip i ,  o2pi, a3 p i, a 6 p i, a7pi, a6p4) and is the most well 
researched of all the laminin isoforms.
In addition to integrin specific adhesion molecules, it was necessary to identify a 
marker of dynamic integrin signaling that was likely the result of cooperation between 
integrin signaling cascades. Intracellular calcium (Ca^^ flux is a likely candidate as it is a 
consequence of, and required for, integrin mediated adhesion and migration [6  and
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Figures. 1-3]. Increases in Ca^  ^are seen upon cell attachment to ECM in platelets, 
macrophages, neutrophils, osteoclasts, smooth muscle, epithelial, and embryonic stem 
cells [7 ,8 ,9]. The complex spatio-temporal aspects of Ca^^ signaling make it well suited 
for the modulation of highly coordinated processes such as migration, which require an 
asymmetric regulation of cell adhesion, with formation/strengthening at the front and 
disassembly/weakening at the rear [10]. Aside from being a factor which regulates 
integrin affinity and avidity, several proteins which modulate F-actin assembly or 
maintenance of focal adhesions are also regulated by calcium flux. These include 
calreticulin, calcineurin, calmodulin, calcium and integrin binding protein, gelsolin, 
calpain, and calcium/calmodulin dependent kinase II (CamKII) [4, II , 12,13]. The 
variety of mechanisms by which Ca^  ^can be regulated also indicate that this is a good 
molecule for analyzing dynamic regulation by the family of integrin receptors.
The mechanism by which calcium fluxes are propagated and maintained by adherent 
and/or actively migrating cells is not completely understood. It is generally accepted, 
however, that intracellular calcium flux results from calcium entry form both internal and 
external sources. Nearly all cells carry receptor-operated and voltage-operated channels 
in the plasma and ER membranes, and store operated Ca^^ charmels which are activated 
by a decrease of Ca^^ in the ER [14] .Opening of Ca^  ^charmels of intracellular Ca^  ^stores 
occurs via inositol-1,4,5-trisphophate (IP3) binding, which is produced by the action of 
membrane bound phospholipase C (PLC) from the substrate phosphatidyl inositol-4,5- 
bisphophate (PIP2). Sustained Ca^^  release is thought to be achieved by the opening of 
Ca^  ^release activated channels (CRAC) of the plasma membrane [12]. The signaling
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molecules PLCyl, CaMKII, calcineurin, and calreticulin are all implicated in stimulating 
Ca^^ influx through plasma membrane channels [8 , 1 1 ].
Although it has been reported that integrin-ECM interactions lead to IP3 production, 
no direct link between integrins and PLC activation has yet been established. A 
convincing model of indirect activation, however, has recently emerged. In this model, 
phosphatidylinositol-3,4,5-trisphophate (PIP3) interacts with PLCy, thus targeting PLCy 
to the membrane and contributing to its activation. PIP3 is produced from PIP2 by the 
action of phosphatidylinositol-3 kinase (PI-3K), an integrin associated kinase. Integrin 
binding activates PI-3K through the activation of FAK [12]. Published data in support of 
this model include demonstration that PI-3K regulates PLC mediated Ca^  ^signaling [15], 
PI3 kinase targets PLC to the membrane [16], integrin binding activates PI3 kinase, and 
PI3 kinase promotes and is required for breast carcinoma invasion [17].
In this research, I identify three integrins expressed by the breast epithelial cells 
MCF-lOA and MDA-MB-231 as potential receptors for intact laminin-1.1 show that 
intracellular calcium flux is required for adhesion to laminin-1, and that intracellular 
calcium flux is dependent upon the type of matrix and integrin engaged. Furthermore, I 
describe the production of six recombinant fragments of laminin-1  by baculovirus 
expression system. Unfortunately, none of the recombinant proteins functioned as 
efficient integrin ligands, and the potential causes of this result are discussed.
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Materiab and Methods
Calcium Detection
Cells were serum starved for 45 minutes and trypsinized until all cells had released 
the substrate (-10 minutes). Trypsin was neutralized by 5mg/ml trypsin inhibitor 
(Boehringer Mannheim, Germany) in DME. Cells were then washed in DME and held in 
suspension for 30 minutes at room temperature in DME supplemented with 50mM 
HEPES pH 7.4 and 5pM Fluo-3 AM (Molecular Probes, Eugene, OR). 120,000 cells 
were plated per well in a 96 well plate coated as in adhesion assays with poly-L lysine, 
matrix proteins, or anti-integrin antibodies. Fluo-3 fluorescence was measured over time 
at 495nm excitation and 535nm emission in an automated fluorescent plate reader (Tecan 
SPECTRAFluor, Research Triangle Park, NC) warmed to 37°C. Background auto 
fluorescence of coated wells containing media only was subtracted from emission 
fluorescence at each time point.
Virus construction
Domains of murine laminin-1 were amplified by polymerase chain reaction (PCR) 
using sequence specific primers designed to generate single products with endonuclease 
specific 5’ and 3’ ends (Table 1). Laminin-1 cDNAs were generously provided by Y. 
Yamada [18]. The endonuclease digested PCR products were subcloned into the 
pBACgus- 6  transfer plasmid (Novagen, Madison WI) in frame with the gp64 promoter, 
secretion signal sequence, and either a 5’or 3’ 6X Histidine repeat. The cloned product 
was dideoxy sequenced in both directions to confirm proper insertion of the cDNA into 
the multiple cloning site of the plasmid. Recombinant baculovirus was generated by 
cotransfection of the pBACgus-6 /domain transfer plasmids with linearized baculovirus
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Domain cDNA Vector Forward Primer Reverse Primer m Î Xve
aVI 1286(PA2-2) PUC18 TATGATCCATGGTGCG IGATTACGAATTCAAGA Nool lEcoRI 1630 3' 112
GAQCCAGCAGAGA ACAACTGGGGTGAOG 1 1
oM> 1285 (PA04) pud8 GAQGTTCCATOGAGTG iCTTACCTCGAQGrCA Nool iXhd 1775 3" 1573
CTTCTQCTTCGCT ICACTCGGATGCATG ! i
G1 160KA0905) pcONAIamp CTATTACCGCGGAATT GAATAOGCATGCTTA Sadi SpN 1443 S' 6640
CCCAGAQGrCTCC iCTOCCrCACGCTOG ; !
G3 1602(A0905) pcDNAIamp ACTTGACCGCGGTGG iACrCTGCCTAGQCTCT Sadi iAwll 1749 S' 7378
GTCGATTGCCTCAT iTCTGCCAQCAAGCA
G4 1603 (MHOS) pcONAIamp 6TCTTGCCATGGACA IGTCCrrCTCGAGAGC iNool ,XM 725 3' 8078
CATGCTTGCTGGCA ITGCATATCCGCTTC
G6 1604(A0905) pcDNAIamp CTTTATCCGCGGGAA GATTACGCATGCAGA Sadi SpM 579 S' 8764
1 GCGGATATGCAGCT iGGCTGGCGACAGTT
Table 1. Construction of viral transfer plasmid. “CDNA” refers to the plasmid from which 
the domain sequences were amplified. “RE” = restriction endonuclease. “Length” 
indicates the size of the PCR product including overhangs which are removed following 
endonuclease digestion. “Laminin-1 start” refers to the location within the native EHS 
laminin-1 sequence vdiere the sequence encompassing the produced domain starts.
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(BacVector-3000 triple cut virus DNA, Novagen) into Spodoptera frugiperda 9 (Sfi) 
cells maintained in Sf-900 n  SFM media (Life Technologies, Rockville, MD) 
supplemented with 10% fetal bovine serum (FBS, Gemini, CA), 100 U/ml penicillin G 
sodium, and 100 pg/ml streptomycin sulfate (Life Technologies). Successfully 
recombinant transfectants were identified by 5-Bromo-4-Chloro-3-indolyl-beta-D- 
Glucuronic acid (Bio-World, Dublin, OH) digestion and purified by three rounds of 
plaque purification. Cultured supemates.were analyzed for domain expression by 
immunoblot analysis with anti-penta His monoclonal antibodies (Qaigen, Valencia, CA). 
Transfected cell supemates were subsequently used to generate high-titer stocks of 
recombinant viruses for future infections.
Protein production cmd purification
Sf9 cells were infected at >10pfii/cell and incubated at 29°C for 1-2 days in Sf-900 n 
SFM media supplemented with 100 U/ml penicillin G sodium, and 100 pg/ml 
streptomycin sulfate. Cells were collected and lysed in insect cell lysis buffer (lOmM 
Tris-Cl pH 7.5,130 mM NaCl, 1% Triton X-100, lOmM sodium phosphate pH 7.5, 
lOmM sodium pyrophosphate) supplemented with a 1:40 dilution of protease inhibitor 
cocktail for use in poly (Histidine) tagged proteins (Sigma-Aldrich, St. Louis, MO) for 
45min at 4°C and centrifuged at 10,OOOG for 45min at 4°C. Ni-NTA agarose beads 
(Qiagen) were incubated in both cell lysate and cell supemate supplemented with ImM 
Phenylmethylsulfonyl fluoride for four hours at 4°C and collected. Beads were pooled 
and sequentially washed with forty volumes wash buffer (50 mM sodium phosphate, pH 
8 , 300 mM NaCl) supplemented with 80mM imidazole, and sixty volumes wash buffer 
supplemented with 5mM imidazole. Protein fractions were collected in elution buffer (50
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mM sodium phosphate, pH 8,300 mM NaCl, 250 mM imidazole) and tested for purity by 
silver staining (Silver Stain Plus, Bio-Rad Laboratories, Hercules, CA). Each domain 
used in these studies was >95% pure. Typical yields ranged between 20-100 pg/L.
Adhesion Assies
Wells of a 96 well plate were coated for 1 hour at room temperature with laminin-1 or 
recombinant proteins at the indicated concentrations in elution buffer (see above).
Negative control wells were coated for the same time in blotto (phosphate buffered saline 
(PBS) containing 5% nonfat dry milk in (pH 7.4) and 0.1%Tween 20). Uncoated surfaces 
were blocked by incubation at room temperature for 1 hour in blotto, and thoroughly 
washed in PBS. Cells were trypsinized and resuspended in adhesion media (DME, 0.25% 
heat-inactivated bovine serum albumin (BSA), 50 mM HEPES pH 7.4) at a concentration 
of 2.4X10^ cells/ml. Cells were kept in suspension at room temperature for 30mins with 
the indicated treatments. One hundred twenty thousand cells were plated per well and 
incubated in a tissue culture incubator at 37°C for 30 mins. Non-adherent cells were 
removed by gently rocking the plates upside down in PBS for 15 minutes. Adherent cells 
were fixed for 15 minutes in 3.7% formaldehyde and stained for 15 minutes in 40% 
methanol/0.5% crystal violet. Adherent cells were quantified by manual counting using a 
20X objective or by measuring absorption at 595nm following cell lysis in 1%SDS.
Manual counting was used when it was desirable to preserve the plate for future analysis. 
Using a 20X objective, cells were counted in a field that appeared to be 50% confluent 
with cells. Cell number from other representative fields was compared to that number to 
extrapolate percent confluence.
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Glycosylation Analysis
To determine the extent of glycosylation, approximately 2pg of each domain protein 
was cleaved with peptide: N-Glycosidase F (PNGase F) (New England Biolabs, Beverly, 
MA) according to manufacturers protocol and 0-Glycosidase (Roche, Indianapolis, IN).
For 0-Glycosidase cleavage, proteins were denatured for 10 mins at 100 C inO.lM P- 
Mercaptoethanol and 0.1% SDS. Alter cooling, samples were cleaved with 0.5 mU 
enzyme in 10% NP-40,0.IM phosphate buffer pH 6 , and 500pg/ml bovine serum 
albumin. All glycosidase reactions were allowed to proceed for 8  hoiurs at 37°C. 
Immunofluorescence Microscopy
Coverslips were coated overnight at 4°C with laminin-1 or domain proteins in elution 
buffer (see above). MDA-MB-231 cells were plated at a density of 6X10' cells/ml in 
DME supplemented with 50mM HEPES pH 7.4 and 0.25% BSA and allowed to adhere 
for 90 minutes at 37°C. Adherent cells were fixed with 3% paraformaldehyde and 
permeabilized in 0.2% Triton X-100 for 15 minutes each. Non specific antibody binding 
was blocked by 1 hour incubation with 3% BSA in PBS. Focal adhesions were visualized 
by staining for one hour with 1:400 dilution of anti-vinculin monoclonal antibody (Sigma 
Aldritch) in blocking solution followed by 1 hour incubation with 1:2000 dilution of 
rhodamine-conjugated anti-mouse IgG secondary antibody (Molecular Probes, Eugene,
OR). F-actin was stained with 1:40 dilution of FITC-conjugated phalloidin (Molecular 
Probes) following incubation with secondary antibody. Stained cells were visualized with 
a Zeiss LSM confocal microscope using a40X objective.
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Statistics
Statistical significance was deteimined by the ANOVA/T-test with a 95% confidence 
interval using JMP statistical software (Altura Software, Pacific Grove, CA).
Results
Integrin engagement stimulates varied intracellular calcium release
Cells engage ECM matrices with only a subset of expressed integrins, depending on 
matrix specificity. Although there is some overlap, different subsets of integrins are 
engaged by each matrix. In order to determine if different matrices stimulate matrix- 
specific intracellular Ca"^ release, identical numbers of MCF-lOA cells were pre­
incubated with a fluorescent cytosolic Ca^  ^dye (Fluo-3 AM) and plated on different 
matrix ligands. Emitted fluorescence was measured over time (fig. 1). Each matrix tested 
caused the release of a unique concentration of cytosolic calciiun, and all were higher 
than cells plated on poly-L lysine. This is presumably due to the subtypes and quantities 
of integrins engaged. In order to demonstrate that simple clustering of integrin subtypes is 
also capable of stimulating variable cytosolic Ca^  ^flux, cells pre-incubated with Fluo-3 
AM were plated in wells coated with antibodies directed against known laminin-1 
binding integrins and intact lamiitin-1. Each of the integrins that influenced adhesion to 
laminin-1 stimulated an intracellular calcium release that was different fi’om binding of 
the intact molecule (fig. 2). These results suggest that signaling events downstream of 
integrin activation synergistically determine the ultimate concentration of cytosolic 
calcium release upon matrix engagement.
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Figure 1. MCF-lOA cells plated on the indicated substrates release different 
concentration of cytosolic calcium over time. Serum starved cells pre-treated for 30 
minutes with 5pM Fluo-3 AM were plated at a concentration of 120,000 cells per well 
in wells of a 96 well plate coated with 20pg/ml of the indicated substrates. 
Fluorescence was measured every 4 minutes in an automated fluorescence plate 
reader at 37’C for the indicated time. The results of a representative experiment are 
shown.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
105
a3
a6
Ln-1
Lysine
A -
5000
15050 100
Time (minutes)
Figure 2. MCF-lOA cell plated on anti-integrin antibodies release different 
concentrations of cytosolic calcium over time. Assay conditions are 
identical to figure 1. Error bars indicate standard deviation (p = 0.05, n = 4).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
106
Fluo-3 AM is a cell permeant dye whose excitation is increased upon binding free 
calcium. The acetomethyl (AM) ester is cleaved in the cytosol, thus restricting the dye 
fix)m entering intracellular calcium stores. While intracellular calcium release occurs with 
release of distinct concentrations and with frequencies of distinct period [19], this dye is 
capable of measuring only total release of calcium over time under the conditions used 
[20]. With a high affrnity for calcium, (Kd=325nM), this dye is likely to bind all free 
cytosolic calcium [20]. Fluorescence measurements therefore reflect accumulation of 
total calcium released by flux o f calcium release over time. The fluorescence 
measurements reported are not likely to have arisen from changes in pH. The test media 
was buffered (see materials and methods), Fluo-3 AM is non fluorescent in the absence 
of calcium and is relatively insensitive to changes in pH. In fact, this dye is used with pH 
sensitive dyes for simultaneous calcium and pH determinations [20, 21].
At the end of each determination assay, cells were washed vigorously in PBS 
and the number of cells remaining were counted as in adhesion assays (data not shown).
The number of adherent cells was roughly inversely proportional to cytosolic calcium 
release. Laminin-5 is the preferred adhesive substrate of these cells [22], and caused the 
least release of cytosolic calcium of all the matrices tested (Fig. 1). This suggests that 
cells loosely adherent or actively migrating within the well released more frequent 
calcium fluxes, or more calcium per release event.
MCF-lOA engagement to laminin-1.
To determine the binding properties of MCF-lOA cells on laminin-1, cells were pre- 
incubated with function blocking antibodies directed against integrins expressed by 
MCF-lOA cells, a chelator of cytosolic calcium (BAFTA-AM), and the PI-3 kinase
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inhibitor wortmannin (Fig. 3). Cells were also incubated in heparin sulfate to demonstrate 
that adhesion to laminin-1 is not dependent upon non-specific charged proteoglycan- 
heparan interactions. Blocking integrins a l ,  a6, and pi inhibit adhesion of MCF-lOA 
cells to laminin-1 indicating that these are the primary integrins that determine the 
strength of adhesion to lam inin-1. a6 is an integrin chain that can form a dimer with 
either p 1 or P4 integrin chains. Because blocking P4 has no effect on adhesion (Fig 3.
Lane 14) a6 are binding laminin-1 in the a 6 p i configuration. Although not statistically 
significant, blocking o3 appears to increase the strength of MCF-lOA cell adhesion to 
laminin-l. Integrin o3 is included in these studies as a potential laminin-1 binding 
molecule due to reports that a3 acts as a negative regulator of a6 activity in other cell 
lines [3]. MCF-lOA engagement to laminin-1 is dependent upon cytosolic calcium as pre­
incubation with BAPTA-AM abolishes adhesion (Fig. 3, lane 3). Integrin mediated 
release of cytosolic Ca^  ^is partially dependent upon the activity of Pl-3 Kinase as 
wortmannin, a specific inhibitor of PI-3 kinase at the concentrations used, blocks 
adhesion in a concentration dependent maimer (Fig. 3, lanes 4,5).
Laminin-1 domains as putative integrin engagement sites.
A comprehensive analysis of stmcture/function studies conducted with EHS laminin- 
1 indicates that cellular fimction can be localized to distinct globular domains on each 
arm of the laminin-1 subunits (Fig. 4) [23-50]. These studies were conducted with either 
protease cleavage fragments of laminin-1 or small overlapping peptides derived from the 
lam inin-1 sequence. Only rarely was a specific fragment or peptide implicated as a ligand 
of a specific integrin subtype. Because the large protease cleavage fragments are likely to 
be bound by more than one integrin subtype, and because small peptides are unlikely to
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Figure 3. Properties of MCF-lOA adhesion to EHS laminin-1.120,000 cells 
per well were plated with the indicated compounds in wells coated with 
20pg/ml laminin-1. Ln-1 = laminin-1 alone, BAPTA = BAPTA-AM,
W = wortmannin. Error bars indicate standard deviation (p=0.05, n=8). 
Diamonds indicate a significant difference from uninfluenced adhesion to 
intact laminin-1.
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Figure 4. Synopsis of structure/function studies conducted with laminin-1 on various cell types from the recent literature.
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form conformations similar to the native molecule, I decided to produce several 
individual domains in a eukaryotic expression system. The baculovirus expression system 
was chosen for ease o f use, protein yield, and because proteins expressed in this system 
are generally processed in a manner similar to vertebrate cells. Domains aVI (AVI), 
alVb (AlVb), Gl, G3, G4, and G5 were chosen due to the high probability of having 
biological activity.
Production o f recombinant laminin-1 domains
Six proteins derived from the EHS laminin-1 sequence corresponding to specific 
globular domains were produced. Based on silver-staining of protein elutions, each 
protein was purified to greater then 95% purity (data not shown). Protein yields varied 
from 2-lOpg/L. The molecular weight of each protein conforms closely to the predicted 
size following cleavage of carbohydrate chains (fig. 5). All six proteins are glycosylated 
via N- and not 0-linkages based on gel shifts following cleavage by pan-specific N- and 
O- glycosidases.
Recombinant domains o f laminin-1 produced by baculovirus expression do not support 
integrin mediated adhesion o f MCF-lOA and MDA-MB-231 cells.
In order to screen each recombinant protein as an adhesive substrate for epithelial 
cells, MCF-lOA cells were plated in wells coated with purified proteins and intact 
laminin-1. Due to low concentration of recombinant proteins, wells were coated with 
equimolar amounts of protein (21 .InM), and not identical masses. Statistically reliable 
adhesion to recombinant proteins by MCF-lOA cells was not demonstrated (Fig. 6). 
Manganese, which acts to strengthen integrin engagement, did not influence MCF-lOA 
adhesion to the recombinant proteins (data not shown). When pre-incubated with MCF-
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Figure S. Purified recombinant proteins. Proteins were visualized by western blot 
analysis using anti-His antibody. All proteins are N- and not O-glycosylated as 
demonstrated by gel shift following cleavage by PNGase F (B), or 0-glycosidase (C). 
A = untreated.
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Figure 6. MCF-lOA cells do not reliably adhere to recombinant domains of laminin-1. 
120,000 cells per well were plated in well coated with equimolar concentrations of intact 
laminin-1 (20pg/ml) or recombinant domain proteins (0.3-lpg/ml). Error bars indicate 
standard deviation (p — 0.05, n=18). Diamonds indicate significant difference fiom 
adhesion to laminin-l.
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lOA cells, no recombinant protein influenced adhesion to lam inin-1 (data not shown). In 
order to determine if the failure to bind the recombinant domains was cell line-speciflc, 
MDA-MB-231 cells, which bind to laminin-1 more strongly than MCF-lOA cells, were 
also tested for adhesion. As indicated by pre-incubation with function blocking anti- 
integrin antibodies, MDA-MB-231 cells engaged laminin-1 with the a6|31 integrin (fig.
7, lanes 2-8). These cells did not, however, bind to proteins A6-G4 to any greater extent 
than negative control (flg. 7 lanes 9-13). These cells did show significant adhesion to 
protein G5. This binding, however, was integrin-independent as function blocking anti- 
integrin antibodies failed to influence adhesion (fig 7. Lanes 14-19). Curiously, MDA- 
MB-231 adhesion to G5 was also independent of proteoglycan-heparan charged 
interactions (fig 7, lane 20). This indicates that these cells engage protein G5 via a 
member of another family of adhesion receptors, such as E-cadherin, a-dystroglycan, or 
CD44.
Because epithelial cell adhesion to substrate normally results in formation of focal 
complexes and spreading, MDA-MB-231 cells were incubated on laminin-1 and protein 
G5 for 90 minutes, and visualized by fluorescence microscopy. Focal complex formation 
was visualized indirectly with anti-vinculin antibody, and actin structure was visualized 
by staining the actin cytoskeleton with fluorescein-conjugated phalloidin (fig. 8). MDA- 
MB-231 cells spread and formed distinct focal complexes on laminin-1 (fig. 8, panel 
A,B). On protein G5, adherent cells remained rounded and did not form any distinct 
cytoskeletal structures or focal complexes (fig. 8, panels C,D).
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Figure 7. Properties of MDA-MB-231 cell adhesion to laminin-1 and protein G5. Assay 
conditions are identical to figure 3. Error bars indicate standard deviation (p = 0.05, n=4). 
Diamonds indicate significant difference fiom adhesion to laminin-1.
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Figure 8. Morphology and focal conykx formation of MDA-MB-231 cells adherent to 
laminin-1 and protein G5. Focal adhesions o f cells adherent to laminin-1 (panel A) and 
protein G5 (panel C) were visualized by staining for the focal adhesion marker vinculin. 
Actin structure of cells adherent to landnin-1 (panel B) and protein G5 (panel D) were 
visualized by staining with the F-actin binding molecule phalloidin.
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Discussion
Failure of the recombinant proteins to support adhesion may be due to altered 
conformations, low concentration, or artifacts of the baculovirus expression system.
Because Sf9 are invertebrate cells, it is possible that the proteins are processed differently 
than they would be by vertebrate cells. The baculovirus system, however, uses many of 
the protein modification, processing, and transport systems present in higher eukaryotes, 
including myristilation, palmitilation, phosphorylation, protein targeting, and cleavage of 
signal sequences. A difference of concern, however, is that N-linked oligosaccharides in 
insect cells are only high mannose type. They are never processed to the complex 
oligosaccharides containing fiicose, galactose, and sialic acid seen in vertebrate cells.
This is only of concern if integrins require the presence of specific carbohydrate 
structures for ligand recognition. Non-glycosylated laminins have been reported to be 
adhesive [51], and non-adhesive (Y. Yamada, personal communication). 0-linked 
glycosylations have been shown to occur in insect cells, but are less well characterized 
[52,53].
In addition to altered glycosylation, the low yield of my system could also be 
responsible for the lack of biological activity of these proteins. In the construction of all 
recombinant viruses I chose the late gp64 promoter, as opposed to the more common 
very late polyhedrin (polH) promoter. The gp64 promoter typically produces 60% the 
yield of the stronger polH promoter but is active at a stage of viral infection when the 
protein processing machinery required for efficient production of secreted proteins 
remains intact [54]. The small size of the proteins (16-45kD) also contributed to low 
yield when measured by weight, as smaller sequences are transcribed no more frequently
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than longer sequences preceded by the same promoter region. Small proteins stored at 
low concentrations also tend to be less stable over time and less able to withstand freeze- 
thaw cycles. The low yield necessitated the use of low concentrations for all assays. All 
intact lam inin-1 was used at a concentration o f 20pg/ml, while each domain protein was 
used at -l^ig/ml, which represents a 1:1 domain/intact laminin-1 equimolar ratio 
(21.1nM). MCF-lOA and MDA-MB-231 cells, however, both adhered to laminin-1 
plated at 21. InM to nearly the same extent as when plated in wells coated with 20pg/ml 
laminin-1 (data not shown).
Although yield with the baculovirus system is unpredictable and varies greatly among 
different proteins expressed, the yield in our system could be improved by double 
infection of sf9 cells with viruses containing the domain sequence downstream of both 
the polH and gp64 promoters. This strategy would extend the time of protein expression 
during viral infection and take advantage of the stronger polH promoter, but would 
require constructing, purifying, and amplifying an additional six viruses. A prudent 
continuation of this work would be to produce proteins from the same DNA sequences 
described here in another system that may provide a greater yield. Other protein 
expression systems that may prove successful include direct transfection of bacterial. 
Drosophila melanogaster, yeast, or mammalian cells.
The adhesion of MDA-MB-231 cells to protein G5 may be due to specific laminin- 
dystroglycan interaction. Dystroglycan is a heterodimeric integral membrane 
glycoprotein receptor for several ECM molecules including laminins. It is expressed in 
many epithelial cell types and binds laminin through G domains. In mice knockout 
studies, it is shown that laminin-1, p i integrins, and dystroglycan are required at the same
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development stage, when the basement membrane first appears [55]. In addition, it is 
demonstrated that dystroglycans have affinity for laminin in the low nanomolar range 
[56].
The use of synthetic peptides is omitted here as a realistic model of integrin ligands. 
Although they are widely demonstrated to effectively inhibit tumor cell adhesion to ECM 
and other cells, stimulate anoikis, and decrease tumor cell métastasés in vivo, they are not 
demonstrated to be activators of integrin function. For example, the binding of a peptide 
that blocks adhesion to laminin is itself blocked by only the a6 and not the p i anti- 
integrin antibodies [23]. In addition, most integrins require either magnesium or calcium 
in sites away from the binding domain. For this reason, integrin mediated adhesion is 
typically blocked by EDTA. Adhesion to integrin binding synthetic peptides are not [23]. 
This data indicates that the peptides are functioning to block the integrin binding sites but 
are not mimicking the binding to an intact native ligand. Lastly, the minimum size of 
fibronectin derived peptide that still preserved the total binding activity is a fir^ment 
with a molecular weight of 75kDa [57].
While the recombinant proteins generated proved not to be reliable integrin 
substrates, I believe that the generation of recombinant proteins that can activate specific 
integrin subtypes by natural receptor/ligand interaction on a variety of cell types will be 
valuable integrin research tools. I favor this strategy over the production of transfected 
cells that express only defined integrin subtypes as recombinant cells expressing foreign 
integrins may not have the cellular machinery required to propagate native integrin- 
stimulated signals. In addition, recombinant domains would be more flexible research 
tools as they could be used with several cell types as well as in different combinations.
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without having to produce doubly and triply transfected cell lines. Lastly, recombinant 
domains could be useful for more than just the study of adhesion, but other functions 
relevant to cancer progression including cell cycle control, prevention of apoptosis and 
migration-associated tissue remodeling [58].
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CHAPTER 6
GENERAL DISCUSSION
My ultimate goal in studying integrin-mediated adhesion, migration, and signaling is 
to identify targets for the design of chemotherapies that function to inhibit the progress of 
human cancers. Despite enormous efforts by clinicians and researchers, cancer is the 
second leading cause of death in the United States [1]. The five year relative survival rate 
for all cancers combined is 59%. The National Institutes of Health estimate overall 
aimual costs for cancer at $107 billion; $37 billion for direct medical costs (total of all 
health expenditures), $11 billion for indirect morbidity costs (cost o f lost productivity due 
to illness), and $59 billion for indirect mortality costs (cost o f lost productivity due to 
premature death). Treatment of breast, lung, and prostate cancers account for over half of 
the direct medical costs [1].
One of the primary reasons for the high morbidity of cancer is the frequent 
ineffectiveness of currently available chemotherapeutic agents. Most cancer patients are 
diagnosed at a time when métastasés are already evident. At this stage, surgery is never 
effective at curing disease, and the patient requires adjunct chemo- and/or radiotherapy 
[2].
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Although pathologically and clinically similar, tumors result from distinctive genetic 
anomalies. For that reason, tumors with identical histologies can respond differently to 
the same chemotherapies [3,4]. In fact, no single regimen has ever been demonstrated to 
be effective in 100% of patients with a given tumor type. Most oncologists, however, 
choose chemotherapy regimens based on standard tumor classifications obtained from 
histology and empirical data from clinical trials. For this reason, patients frequently 
receive treatments of no therapeutic value. These therapies are then altered until an 
acceptable patient response is achieved. This process can be detrimental by prolonging 
growth of disease, negatively influencing general patient health and morale, and 
substantially increasing cost and length of medical care. In addition, many patients who 
have a high probability of being completely refractory to chemotherapy treatment suffer 
the side effects of hopeless drug therapies [5].
Aside from early detection, there are two strategies for improving the morbidity of 
cancer. One is to discover new classes of anti-cancer compounds that attack tumors in 
unconventional ways. A second is to improve the efficacy of current therapies by 
tailoring chemotherapy treatment for patients on a case-by-case basis. In order to 
accomplish these tasks, assay systems need to be developed that can measure the 
response of human tumors to chemotherapies, develop new techniques for relating 
preclinical information to clinical results for prediction of future useful clinical agents, 
and gain a greater understanding o f the specific molecular mechanisms that govern 
cancer progression.
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Assay Development
At present, nearly all anticancer chemotherapies function to kill a patient’s tumor 
cells. But the most dangerous cancer cells do more than grow: they metastasize by 
migrating away from the initial tumor and spreading throughout the body. Because it 
quantifies migration as well as cell death, the protocol described in chapter two has the 
potential to be used as a high-throughput method for discovering novel anti-cancer 
compounds that function to inhibit cell migration.
In addition, this assay has the potential to be used to tailor drug therapies for 
individual patients. Distinguishing which population of patients will respond to a specific 
drug before chemotherapy begins, can help the treating oncologist choose the best 
therapy route. For example, only 20% of colon cancer patients respond to 5-fluorouracil 
[6]. Patients whose biopsies are identified as sensitive to 5-fluorouracil have a much 
better than 20% response and those patients whose biopsies are identified as resistant are, 
depending on the assay, nearly always unresponsive. If the type of tumor being treated 
has a low likelihood of response to chemotherapy, such as melanomas, NSCLS and GI 
neoplasms, a biopsy test can help the oncologist decide whether to treat with 
chemotherapy at all. If the type of tumor typically does respond to chemotherapy, such as 
breast, ovarian, and most small cell lung cancers, such a test will help select the most 
effective, least toxic regimen. If the type of tumor is a generally "curable" cancer such as 
hematologic neoplasms, the test will help determine the most potentially curative from 
amongst comparable choices. Also, knowing when to stop treatment in hopeless 
situations is as important as any other management issue [7,8].
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The technique of diagnosing a patient’s response to chemotherapy, before 
chemotheTsq)y begins, is termed an In-Vitro Chemosensitivity Assay (IVCA) [9,10,11]. 
Unfortunately, the widespread use of IVCA has been hindered by failures o f early assays 
to predict patient outcome [10]. This could be due to the fact that all o f the currently 
available FVCAs measure only the effectiveness of drugs on blocking the growth of 
malignant cells through quantification of cell proliferation, cell death, or production of 
intracellular metabolites such as ATP. Therefore, the advantages of the assay described in 
chapter two also lend it to be used as an IVCA system that is potentially more pertinent, 
sensitive, and effective than existing diagnostic methods. Convergence o f cell migration 
and cell death data will minimize the occurrence of false positive and false negative 
responses, and improve the validity of true positive and negative responses. In addition, 
this assay does not require cell cloning, a process that introduces bias by selecting 
clonogenic cells fi‘om a heterogeneous biopsy.
The main argument against IVCA is that it has never been shown in prospective 
randomized trials that there is a clear advantage to chemotherapy selected with the 
benefit of knowledge of the IVCA results compared to chemotherapy selected without 
knowledge of the IVCA results [7,9]. This is not because studies were carried out and 
failed to show a difference. It is because the studies have never been supported and 
carried out by the NCI, NCI-CCCs and university cancer centers [10]. Arguments in 
favor include that scores of studies have consistently shown a significantly greater benefit 
for treatment with drugs that are active in the tests compared to treatment with drugs that 
are inactive in the tests. Additionally, a growing niunber of studies have shown a superior 
survival for patients treated with drugs that are active in these tests [10].
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Despite these successes, the full potential of IVCA has not yet been realized.
Problems associated with all IVCA techniques can essentially be summed up by stating 
that no in vitro assay can completely duplicate in vivo conditions. For example, most 
assays require that the biopsy cells are expanded in culture before testing. This allows 
selective expansion of subsets of tumor cells so these assays may not be predictive of 
responses of original tumor cells. Assays using differential cell staining techniques are 
subject to individual interpretation, and frequently carmot distinguish live cells from 
cellular debris. Measurements of cellular metabolism cannot discriminate cells that are 
injured and will recover from those which are truly dead. Assays using cell proliferation 
as the only valid endpoint have failed to predict clinical outcomes for cancer patients 
[12]. Lastly, all assays that measure a single biochemical endpoint such as inhibition of 
DNA synthesis may not accurately reflect cell survival, or may be influenced by cell 
injury during tissue isolation. Nevertheless, assays such as the one described here need to 
be continually developed and refined to fully realize a potentially valuable treatment tool. 
Basic Research
A major problem facing researchers in the integrin field is that a large number of 
intracellular molecules interact with integrins, yet no clear identification of their 
individual functions is known. [13]. For example, focal adhesion formation is not always 
required for integrin linked signaling, and when it is, proteins involved in numerous 
signaling cascades are found at focal contacts [14].
In addition, it is difficult to differentiate the function of integrins. Integrin modulated 
enhancement in metastasis formation may not be due directly to mechanisms of invasion, 
but due indirectly through control of the cell cycle and prevention of apoptosis. To
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further complicate matters, integrin function can be cell-type specific. For example, 
different tumor cell lines can become more or less tumorigenic with up or down 
regulation of the same integrin [15]. The research presented here raises similar 
conundrums.
In chapter three, I identify hsp27 as a factor which resists the effects of anti-migratory 
compounds on integrin-mediated migration. Although it cannot be ruled out as a 
promising chemotherapeutic target, this does not imply that hsp27 is a mandatory 
constituent of pro-migratory integrin-linked signal cascades. In addition to being an anti- 
apoptotic agent, hsp27 can increase cellular resistance to heat shock and oxidative stress. 
This protection is the result of several hsp27 actions. It is shown to be a molecular 
chaperone, to interfere with caspase activation, and influence cytochrome C stimulated 
signaling [16, S.W. Carper, personal communication]. Its action in migration may be an 
indirect effect o f general survival functions.
In chapter four, I demonstrate that integrins can employ heterotrimeric G-proteins in 
pro-migratory signaling. It is also known that G-proteins can mediate rapid activation of 
the MAP kinases ERK 1/ERK 2 [17,18]. These kinases are integral to pro-migratory 
signaling and are linked to integrin activation by at least two other separate pathways. 
Heterotrimeric G-proteins can also influence the activity of FAK associated proteins such 
as Src, and Pyk2 [19]. Does this imply that, like hsp27, G-protein activation is an indirect 
consequence of activation of diverse signal transduction mechanisms also involved in 
pro-migratory signaling? It is also entirely plausible that integrins activate G-proteins by 
directly stimulating G-protein coupled transmembrane receptors. It seems the only
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consistent truth is that cellular behavior is a consequence o f cooperation between multiple 
signal molecules of diverse function.
In order to understand the interrelationships and interdependencies between signal 
molecules, the researcher must attempt to view a larger role for each molecule besides a 
spot within a linear activation cascade. This trend is seen in the growth of the genomics 
and proteomics fields, where a global cellular perspective replaces a single molecule 
perspective. Once the activators and targets of a kinase are discovered, it follows to be 
discerned where and when specificity of this signaling occurs. For second messenger 
flux, such as intracellular ions, cAMP, or phospholipid bursts, the specificity arises firom 
localization within the cell, concentration, and period [20-22]. For example, the catalytic 
activity of CaMKII is higher upon exposure to calcium flux of a faster period than a 
slower one [23]. For catalytic enzymes, the specificity likely arises from complex 
cooperation between target molecules that impact a similar cellular function.
Therefore, the questions that must be answered are: How does cooperation between 
cascades govern cellular function? What are the critical junctions of this cooperation?
Would an upstream or downstream effector be the most successful target for 
chemotherapy design or genetic manipulation? The hypothesis and model proposed in 
chapter five attempt to provide an angle for answering these questions in the context of 
integrin cooperation. While the recombinant proteins proved ineffective, this work 
demonstrates that integrin cooperation does regulate a dynamic intracellular calcium 
response. This dynamic response is almost certainly the result of intervening kinases and 
other second messengers. It follows that more models need to be developed in the future 
that will give us insight into the cooperative controls of cell behavior. Barring the
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discovery of scores more intracellular kinases, this will, in the author’s opinion, provide 
the best explanations for the emergent properties of cell behavior.
The hypothesis presented in the general introduction of this text states, “...laminin 
binding integrins are capable of independently and simultaneously stimulating several 
intracellular signal cascades that cooperate with one another to regulate the strength of 
adhesion and rate of migration.” The data presented shows the involvement o f two more 
proteins (HSP27 and heterotrimeric G proteins) in integrin-mediated adhesion and 
migration not previously reported. A cooperation between integrin-stimulated signal 
cascades is demonstrated in the regulation of intracellular calcium release reported in 
chapter four. Furthermore, the partial inhibition of migration by specific inhibitors of 
intracellular signal molecules (chapters 3,4), or adhesion by specific integrin blocking 
antibodies (chapter 4), also strongly supports the dependence on communication between 
integrin stimulated signals in the regulation of these activities. Future exploration of this 
phenomena should include the production of biologically active laminin domains 
described in chapter five, followed by analysis of G-protein, HSP27, and intracellular 
kinase activity in cells plated on those domains. The analysis made here predicts that 
these proteins will be activated by specific integrins. Lastly, the activation state of all of 
those proteins at specific points in time will simultaneously control cellular adhesion and 
migration.
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